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INTRODUCTION TO NUCLEAR MAGNETIC RESONANCE 
SPECTROSCOPY 
The nuclear magnetic resonance phenomena was discovered in 1946 by Purcell and 
Bloch ч I M This technique is based on the involvement of the interaction between the 
magnetic moment (nuclear spin) of certain nuclei and a magnetic field Ml 84 For 
example, nuclei with a nuclear spin of 1/2 will have two orientations with slightly 
different energy levels which are proportional to the magnitude of the applied field 
Transitions between these two energy levels can be induced by the application ot a 
radiotrequency pulse The exact frequency depends on the magnetic field and the 
magnetogync ratio Since the magnetogync ratio varies from one isotope to another, 
different nuclei present in the same magnetic field will have different observation 
frequencies As a consequence only one nuclear isotope can be studied at a time 
Moreover, the spatial or chemical environment influences the local magnetic field, and 
the same nucleus in different chemical environments will give rise to resonance signals 
at different frequencies As a result, at a certain field strength, each molecule will 
have a specific resonance pattern Because of this unique property MRS can be used to 
monitor various metabolites simultaneously Since the area under each peak is 
proportional to the concentration of the metabolite, absolute quantification can also be 
performed 
MRS metabolite studies can be performed on a number ot nuclei e g phosphorus, 
hydrogen, deuterium, fluorine, carbon and nitrogen Ή and 3 IP MRS are most 
commonly used in biomedical cancer research Ή Ρ MRS provides information 
concerning energy as well as lipid metabolism The energy metabolism is assessed by 
measuring phosphocreatine, adenosine tri phosphates, inorganic phosphate and the pH 
whereas the lipid metabolism is monitored by the determination of phosphomono 
esters and phosphodiesters Ή MRS is used to monitor compounds such as amino 
acids, lactate, citrate, (phospho)creatine, choline containing metabolites and taurine 
Deuterium MRS is used to measure (tumor) blood flow '"F MRS is currently applied 
to measure the absorption, distribution, metabolism and excretion ot fluonnated drugs 
Finally, 13C and 1SN MRS are used in dynamic metabolic pathway studies 
THE BIOCHEMICAL BACKGROUND OF Ή and J IP MRS 
Energy metabolism 
Glycolysis is a sequence of leactions that converts glucose into pyruvate with 
concomitant production ot ATP, occurring in the cytoplasm of the cell 
glucose + 2 Pi + 2 ADP + 2 NAD+ -» 2 pyruvate + 2 ATP + 2 NADH + 2 H+ + 2H20 
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The end product, pyruvate, will under normal aerobic circumstances be transported to 
the mitochondnae where through oxidative decarboxylation acetylcoA is formed that 
enters the citric acid cycle (figure 1.)· 
Figure 1. Citrate acid cycle Enzymes 1-9 are 1 Citrate synthetase, 2 Aconitase, 3 Aconitase, 
4 Isocitrate dehydrogenase, 5 α-ketoglutarate dehydrogenase, 6 Succinyl Coa synthethase, 7 
Succinyl dehydrogenase, 8 Fumarase, 9 Malate dehydrogenase (Stryer L Biochemistry page 
289, Freeman and Company, New York 1981) 
The citric acid cycle is the main generator ot ATP. Consequently, the need for ATP 
regulates the rate ot the citric acid cycle. Three enzymes play a key role in the control 
of the cycle: citrate synthetase, isocitratedehydrogenase and a-ketoglutarate 
dehydrogenase. 
12 Chapter 1 
In cancer cells or under circumstances where the oxygen supply is insufficient, 
pyruvate will slay in the cytosol where it is converted to lactate 
pyruvate + NADH + H* -> lactate + NAD+ 
Several metabolites of the glycolysis and the citrate acid cycle can be identified in Ή 
and 1 ]P MRS spectra Especially the 1 ]P MRS spectra provide information about the 
bioenergy status of the investigated sample phosphocreatine, ATP as the energy rich 
molecules and inorganic phosphate (Pi) as breakdown product can be accurately 
measured 
Phospholipid metabolism 
The biosynthesis of phosphatidylcholine and phosphatidylethanolamine, known as the 
Kennedy pathway, was elucidated in 19567<i 
choline -> phosphochohne -¥ cytidine-diphosphochohne -> phosphatidylcholine 
This three-step pathway is catalyzed by chohnekinase, phosphochohne cytidyl-
transferase, and phosphochohne transferase respectively Phosphatidylethanolamine 
synthesis requires three analogous steps 
ethanolamine 
phosphoethanolamine 
Φ 
cytidine-diphosphoethanolamine 
phosphatidylethanolamine 
catalyzed by ethanolaminekinase, phosphoethanolamine cytidyltransterase, and 
phosphoethanolamine transferase respectively 
The breakdown of phosphatidylcholine (or -ethanolamine) to lysophosphatidylcholine 
(or ethanolamine), to glyceiophosphocholine (or ethanolamine), to choline (or 
ethanolamine) are catalyzed by the same enzymes phospholipase A, 
lysophosphohpase, and glycerophosphorylcholine phosphodiesterase respectively 
The synthesis and breakdown pathways are closely linked Ethanolamine is an 
inhibitor of choline kinase and of glycerophosphorylcholine phosphodiesterase, 
whereas choline inhibits ethanolamine kinase and also the last step towards choline and 
ethanolamine in the degradation pathways 
In Ή Ρ MRS spectra, various phosphorus containing metabolites can be monitored to 
obtain information about the phospholipid metabolism 
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INTRODUCTION TO IN VITRO MRS 
In vitro MRS analyses have been performed on perfused cells4790, biopsy 
material7 4 4 8 1 0 2 1"1, or extracted tissues or cells. 4 0 6 0 4 7 9 9 1 0 " MRS of cultured cells has 
the advantage that the effects of different environmental conditions such as nutrient 
supply, hypoxia and pH on tumor cells can be investigated. Moreover, cell lines offer 
the possibility to investigate potential diagnostic and prognostic markers of certain 
cancers without being hampered by tissue heterogeneity. Unfortunately difficult MRS 
pulse programs are necessary to ensure that the cells are monitored and not the culture 
media. 
Studying biopsy specimens gives us the opportunity to correlate MRS findings with 
histology.7498"12101 Freshly excised tissues can be placed directly or after storage at -
80° С for up to 6 weeks, in a MRS tube. MRS spectra can be recorded and directly 
afterwards the whole tissue specimen is available for histological examination. The 
pathological findings e.g, the presence of cancer and the percentage of the various cell 
types can now be correlated with the MRS metabolic pattern of the biopsy. Finally, in 
vitro MRS can be done on extracted tissues and / or cells.40 60 97 9 9 1 U 0 The most 
commonly used extraction methods in cancer research are perchloric acid extraction 
and chloroform / methanol extraction. The former is used for the identification of 
small water soluble metabolites and the latter is used for lipid metabolite 
studies. 4 0 6 0 9 7 9 8 9 9 Analysis of extracted samples allows (1) an unambiguous assignment 
of resonances thus aiding assignment of less well-resolvedin vivo MRS spectra (fig. 
2), (2) absolute quantification of metabolite concentrations and (3) facilitates the 
understanding of biochemical mechanisms underlying spectral modifications observed 
during tumor growth or response to therapy. The merits and limitations of in vitro 
MRS are summarized in table 1. 
Table 1. Merits and limitations of in vitro MRS. 
advantages disadvantages 
• High magnetic fields possible · Artifacts may be induced by 
• Homogeneous samples sample handling 
• Highly resolved spectra 
• Easy to quantity 
• High signal to noise ratio possible 
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Figure 2. In vitro and in vivo 81 MHz "P NMR spectra of a control (untreated) NU-1 human 
kidney cancer xenograft The major peaks in the in vitro spectrum (below) are attributed as 
follows, SP: sugarphosphates, PME. phosphomonoesters, PE phosphoethanolamine, PC. 
phosphocholine, Pr inorganic phosphate, PDE· phosphodiesters, GPE glycerophospho-
ethanolamine, GPC. glycerophosphocholine, PCr phosphocreatine, NTP nucleoside triphosphate, 
NDP nucleoside diphosphate, DPDE· diphosphodiester, DPDE, NAD (oxidized nicotinamide 
adenine dinucleotide, DPDE, nucleosidediphosphorylsugars 
Above the in vitro NMR spectrum, two in vivo NMR spectra are shown 
INTRODUCTION TO IN VIVO MRS 
Genetic diseases, inflammatory processes, neoplasms, systemic metabolic and 
endocrine disorders have been studied with MRS.1*51 " ° " 5 " 6 П 0 П 8 1 7 2 Despite 
promising results obtained in in vivo MRS in animal studies, MRS is not routinely 
used in the present clinical practice. Several reasons have to be taken into account. 
First, the broad knowledge of the biochemistry and pathophysiology of the 
investigated diseases which is necessary for the interpretation of the information 
content available in the MRS spectra is lacking. Secondly, many technical difficulties 
need to be resolved in order to obtain high resolution spectra. Finally, since MRS is 
an expensive and relative time consuming procedure, clinical trials are needed to 
address its additional value for diagnosis and treatment of patients. 
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THE APPLICATION OF MRS IN TUMOR CELL BIOLOGY 
Tumor characterization 
One of the investigative goals of current MRS research in oncology is to answer the 
question whether MRS can detect metabolic markers / patterns specific for cancer and 
if so if these are of value in improving diagnosis / detection Several human 
malignancies have been characterized with Ή , M P and n C in vitro 
M R S 2 6 35 74«8iiüimv4S4 I n g e n e r a i changes in the phospholipid metabolism, e g 
increased phosphomonoester / phosphodiester ratios were indicative for 
malignancies261574 '""4 
With respect to in vivo Ή and 11P MRS, the majority of studies have been performed 
in brain malignancies (review Negendank et al ) "° This is due to the fact that high 
resolution MR spectra can be easily obtained because large lipid resonances, that are 
difficult to suppress selectively, are absent in the brain 3 'P MRS studies of human 
cancers outside the brain have revealed that tumors are slightly alkaline and tend to 
contain high levels of phosphomono- and diesters and low phosphocrea-
t i n e π 101 106 шии 117 P7 is] ич p o r a ^ e w malignancies originating outside the brain, 
special metabolic derangements have been described e g , changes in citrate 
metabolism for prostate cancer 10f> 1W> Furthermore melanin has been detected as a 
marker tor uveal melanomas " 
Monitoring tumor therapy 
Changes in the MR spectra after initiation of treatment might correlate with the 
efficacy of tumor treatment The effects of various therapies, e g hormonal-, radio-, 
chemo-, thermo-, immuno and High Energy Shock Waves (HESW) tumor therapy 
have been monitored by in vivo MRS in humans as well as in 
animals 4 2 5 4 " 8 6 8 7 Ι Ι 2 Π 7 , , , 1 " Ι " 1 6 " 6 5 ' 6 9 Π 0 Hormonal treatment of the androgen 
sensitive rat prostate cancer resulted in a significant decrease of PCr / NTP ratio 169 In 
contrast, successful endocrine therapy of rat breast cancer gave a rise in PCr and NTP 
peaks l 1 7 Also for chemotherapy and radiotherapy positive and negative influences on 
tumor energy metabolism have been described, depending on the tumor model, dose 
of irradiation and dose and kind of chemotherapeutic agent ш Hyperthermia as well as 
HESW exposure of human renal xenografts in nude mice resulted in a decrease in 
high energy phosphates, increase of inorganic phosphate and acidification of the 
treated tumors , l 2 1 " 
There have been a limited number of human in vivo MRS studies evaluating 
metabolite changes after therapy Changes in phospholipid metabolism, e g decreased 
phosphomonoesters, have been reported in patients responding to chemo- and 
radiotherapy ' 5 1 ( , 5 S 7 1 " ' m " 4 1 1 2 1 3 " l 1 4 
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Monitoring tumor perfusion 
The efficacy of a number of therapies, e g. chemo-, radio- and thermotherapy, 
depends on the tumor blood flow (TBF) status 4S Hypoxic cells are not sensitive to 
radiotherapy, whereas poor tissue perfusion enhances the efficacy of thermotherapy.71 
The biodistribution of chemotherapeutic drugs, and thus their efficacy, also depends 
on perfusion.71 TBF can also be altered by several treatments, e.g. thermotherapy and 
HESW." "2 Monitoring the TBF before and after treatment is therefore of importance 
in evaluating the efficacy ot such TBF dependent therapies. 
Several methods can be used to measure TBF and perfusion, either directly or 
indirectly.1 The concept of using deuterium (D20) as a MRS detectable tracer in the 
measurement of TBF was introduced in 1978 by Ackerman et al.1 Since then several 
approaches have been contrived to calculate TBF. The tracer, i.e. deuterium, can be 
injected i.v. or directly into the tumor. Both approaches have their advantages and 
disadvantages and both have proven to be sensitive and reproducible methods in the 
determination of TBF and perfusion."1''78 81 Tracer detection can be done by MR 
spectroscopy77 or MR imaging,4^81 "'2 This non-destructive and mostly non-invasive 
technique allows repeated monitoring of the same subject. It is therefore an ideal 
technique to monitor changes in TBF after therapy. 
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OUTLINE OF THESIS 
The application oí magnetic resonance based techniques has expanded in clinical 
medicine in the past tew years In particular, magnetic resonance imaging (MRI) has 
become one of the major new tools in diagnostic radiology Magnetic resonance 
spectroscopy (MRS) is using the same hardware as MRI but provides information at 
the biochemical level The clinical use of MRS however is still in its infancy In this 
thesis the value ot MRS in the diagnosis ot prostate cancer and in monitoring a new 
experimental cancer therapy, high energy shock waves, was determined The tissue 
characterization studies were performed with in vitro MRS on perchloric extracts, 
whereas the therapy monitoring studies were performed with in vivo MRS 
The metabolic characteristics of malignant and benign human prostate tissue, obtained 
with Ή Ρ and Ή MRS, are described in chapter 2 in other to identify metabolic 
differences that may serve as a marker in prostate cancer In chapter 3 investigation 
concerning the metabolic status of different Dunning R-3327 rat prostate tumor lines 
and the relation to their different biological behaviour are described In chapter 4 we 
explore, with Ή MRS, whether metabolic differences between human prostate cancer 
cell lines with different biological behaviour exist 
In vivo M P, Ή and 2H MRS studies were performed to monitor the effects of HESW 
on tumor tissue In chapter 5 we corroborated the hypothesis that the vascular 
functionality is an important target of HESW by monitoring TBF and 'H MRS In 
chapter 6 the effects of successive HESW exposures on tumor blood flow are 
evaluated with 2H MRS The summary and the conclusions of this thesis are given in 
chapter 7 

Chapter 2 
CHARACTERIZATION OF HUMAN PROSTATE 
CANCER, BENIGN PROSTATIC HYPERPLASIA AND 
NORMAL PROSTATE BY IN VITRO lH AND 31P 
MAGNETIC RESONANCE SPECTROSCOPY 
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INTRODUCTION 
Prostate cancer is an increasing medical problem it is now the most common cancer 
in the western male population and the second leading cause of cancer related death in 
men " The approach to treatment depends on the stage of the cancer at the time of 
diagnosis Unfortunately, present methods for the detection ot prostate malignancy 
(e g prostate specific antigen, transrectal ultrasonography and digital rectal 
examination) are inadequate to assign the precise tumor stage and to predict tumor 
behaviour 2" Therelore, new methods to improve prostate tumor staging are necessary 
As yet, the clinical introduction ot magnetic resonance imaging (MRI) did not 
significantly improve the detection and staging of prostate cancer 88 '•"' Recently 
transrectal probes were introduced that not only improved the quality of MRI but also 
made the prostate accessible to magnetic resonance spectroscopy (MRS) т [0Ь '4 7 MRS, 
basically employing the same instrumental set-up as for MRI, is able to monitor tissue 
metabolism non-invasively 
1 J P, Ή and n C MRS have been used in studies that tried, both in vitro and in vivo, to 
associate relative levels of metabolites with benign or malignant prostate 
lesions 4" *2 m юь "" u ' ' " ^ 4 1 7 4 It has been suggested that the relative levels of the 
phosphorylated metabolites phosphocreatine (PCr) and phosphomonoesters (PME) can 
be used to discriminate malignant from benign tissue Wb Other investigators were able 
to measure the citrate concentration in prostatic tissue using Ή MRS ib>i2 ,AS 1 4 6 1 7 4 
Moreover, Sillerud and associates demonstrated with the help of n C MRS a difference 
in relative levels of citrate between the normal and malignant prostate both in vitro 
and in vivo l 5 1 1 5 4 
The current study was designed to characterize both Ή and 1 1P MRS spectra ot benign 
and malignant prostate at high fields in order to substantiate these observations and to 
identity further differences that may serve as markers for malignancy Considering the 
spectral overlap occurring for spectra of whole tissue species, we decided to analyze 
perchloric acid (PCA) extracts in which resonances are relatively well resolved and 
easy to assign 
MATERIALS AND METHODS 
Tissues 
Prostatic tissue, obtained by transurethral resection (TURP) was snap frozen in liquid 
nitrogen within 30 seconds after the start of resection This short ischaemia time 
should prevent the gross occurrence of anaerobic glycolysis and break down of high 
energy phosphates Samples ranged in size from 0 9 to 3 6 grams Tissue of patients 
with benign prostatic hyperplasia (BPH) (N = 7), patients with advanced 
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adenocarcinoma of the prostate (N = 4) and one patient with no signs of malignancy or 
BPH (NP) were included in this study. 
Histology 
Before processing the tissue samples for PCA extraction, 4 to 5 representative biopsies 
of one lesion (total material taken ± 0.20 grams) were taken tor histological 
examination to confirm the diagnosis and to correlate possible differences in the 
proton and phosphorus spectra with the percentage of normal, BPH or cancerous 
tissue. Only for one prostate adenocarcinoma sample it was impossible to perform 
such an additional histological examination. 
Preparation of PCA tissue extracts 
PCA extraction was performed as described earlier by Smits et al.1" In short, frozen 
tissue was weighed and pulverized at -80 ° C, transferred into an all glass 
homogenizer and 0.9 M PCA was added dropwise to a total of five times the weight 
of the tumor Complete tissue homogenization was achieved in approximately 30 
minutes. 
After centrifugation (12,000 g, 15', 4° C) of the tissue homogenates, the pellet was 
discarded and the pH of the supernatant was immediately adjusted to 7.5 with 9 M 
КОН. The PCA precipitate was centrifuged (12,000 g, 15', 4° C) and the supernatant 
was passed through a Chelex sample preparation disc (Bio-Rad Laboraties, Richmond, 
USA) and lyophilized. Lyophihzates were stored at - 20° С Thirty percent ot the 
lyophilizate was used for Ή MRS and 70 % for ""P MRS 
Before the 'H MRS measurements, the lyophihzates were carefully thawed and 
dissolved in 500 μΐ 20 mM potassiumphosphate buffer pH 7.0. If necessary the pH 
was adjusted to pH 6.9-7.1 Thereafter the samples were lyophilized and dissolved in 
500 μ\ D,0 with 1.6 mM 3-(Tnmethylsilyl) propionic acid-d4 sodium salt (TSP). 
For the ^P MRS measurements the lyophilizate was dissolved in 450 μΙ 0.5 mM 
dimethylphosphate, 20mM EDTA, 10 mM Tris, pH 7.8 in 30% D 2 0. 
"P MRS measurements 
The 4P MRS spectra were acquired on a 200 MHz spectrometer (Bruker WM200) and 
were recorded with a standard 5 mm λ1Ρ MRS high resolution probe employing a 50° 
flip angle and a pulse repetition time of 4 sec. WALTZ-16 low power broadband Ή 
decoupling was used during data acquisition. The PCA extracts were analyzed under 
spinning conditions with a linewidth of the H 2 0 signal between 1 and 3 Hz. The 
chemical shifts were referenced with respect to the chemical shift position of the 
phosphocreatine resonance 
The MRS data were further evaluated employing the NMR1 package (New Methods 
Research, INC, Last Syracuse, NY, USA) on a SUN Sparc station 330 (Sun 
Microsystems, INC, Mountain View, USA). FIDs were Fourier transformed and the 
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phase was manually corrected The MP MR spectra were semiautomati-cally fitted to 
Lorentzian lineshape model functions To enable comparison of different spectra, 
relative integrals of phosphor metabolite resonances of interest were expressed as ratio 
to the total integral values of all phosphates signals (TP) in the sample 
'H MRS measurements 
One and two dimensional Ή MRS spectra were acquired on a 500 MHz spectrometer 
(Bruker AM500) and were recorded with a standard 5 mm 'H MRS probe One 
dimensional Ή MRS spectra were recorded employing a 45° flip angle and a 7 3 sec 
pulse repetition time The resonance of H20 was suppressed by low power continuous 
wave presaturation 
The chemical shifts were relerenced with respect to the chemical shift position of the 
TSP resonance 
Ή MRS spectra were evaluated with NMR1 software FIDs were Fourier transformed 
after zero filling from 8 К to 32 К and Lorentzian to Gaussian transformation The 
phase was manually corrected and the spectra were semiautomatically fitted to 
Gaussian lineshape model lunctions To enable comparison of different spectra, 
relative integrals of proton metabolite resonances of interest were expressed as ratio to 
the total amount of the relative integral of the methyl resonance of lactate or total 
creatine (phosphocreatine plus creatine) 
Homonuclear Ή-Ή MRS measurements 
For Ή spectral assignments double quantum filtered correlated (DQF COSY) 
spectroscopy was performed using time proportional-phase incrementation with a 
spectral width of 6 KHz Spectra were acquired with 512 data points in the t, direction 
and 2K data points in the t, direction Ч4 Р 6 The time domain data was zero filled and 
multiplied with a shifted sine-bell function before Fourier transformation 
Statistical analysis 
Differences in ratios of metabolites between the BPH and adenocarcinoma groups 
were investigated by the Kruskal-Wallis test at an experimental error rate of 0 05 
RESULTS 
The results of the histopathological evaluation of the specimens used for PCA 
extraction were compared with the pathology reports and confirmed that representative 
samples of the tissues were investigated All adenocarcinomas had a Gleason score of 
more than 8 Semiquantitative estimation of the percentage of tissue in the prostate 
cancers that could be evaluated showed more than 70% of tumor in two prostate 
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cancer samples In these two samples no signs of normal epithelial structures or BPH 
compounds were seen One sample of prostate cancer consisted of 60 % 
adenocarcinoma, no BPH and less than 5% normal epithelial structures were found 
One BPH sample consisted for almost 100% of glandular hyperplasia In the other six 
samples the percentage ol BPH was 40-50% with 10-20% normal epithelial structures 
It must be emphasized that the number oí patients with BPH and adeno-carcinoma of 
the prostate are small Moreover, all tumors are in an advanced stage Our results, as 
presented below, should therefore be considered as the first step in characterization of 
the metabolic content of the prostate and evaluation of the metabolic state ol BPH and 
advani ed prostate cancer 
j^ jJ l lUL^i^ 
) Л Ш 
Figure 1. In vitro Ή NMR spectrum with two expanded parts, of a PCA extract ot normal 
prostatic tissue Peak assignments are indicated 
Ή Nuclear Magnetic Resonance Spectroscopy 
A 500 MHz proton MRS spectrum of a PCA extract ot normal prostate tissue, with 
two expanded parts, is shown in figure 1 Numerous resonance peaks, originating 
from protons of prostate compounds can be distinguished in the spectrum 
Assignments for the methyl singlet peaks of phosphochohne (PC), choline (Choi) and 
(phospho)creatine ((P)Cr) were taken from the literature 4 0 1 2 4 A number of other 
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resonances were identified with the help of the double-quantum filtered correlated 
(DQF-COSY) homonuclear 'H-'H spectroscopy (Figure 2). 
h I V i -^_J\AJ^ 
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/ 
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Figure 2. Double-quantum filtered correlated (DQF-COSY) homonuclear 'H-'H spectra (A), with 
one expanded part (B) of a PCA extract of normal prostatic tissue Cross peak connectivities used 
for assignments are indicated with arrows 
In Figures 2A and 2B proton-proton connectivities are indicated in the COSY spectra 
used for the assignment of lactate (Lac), alanine (Ala), citrate (Cit), taurine (Tau) and 
inositol (Ino). Many more connectivities were observed that may serve identification 
ol other compounds. However, for this study we have restricted ourselves to an 
analysis of prostate compounds contributing to the most dominating resonances in the 
spectrum. These resonances are also expected to be important for in vivo MRS 
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studies. For each compound the best resolved resonance(s) were selected for 
quantitation purposes. A signal of a stable homogeneous distributed compound would 
be ideal as an internal tissue standard for quantitation. Such a compound is not 
available for the prostate and we have adopted the signals of total creatine (TCr) for 
quantification (creatine plus phosphocreatine is relatively stable during hypoxia and 
prolonged ischemia), but these may differ as a function of muscular content or tumor 
tissue.7д|Ю 
Table 1. Ή MRS relative peak integral ratios of prostatic human tissue. 
(issue 
Ala/TCr 
С it/Lac 
Cit/TCr 
Cit/TChol 
Chol/TCr 
PC/TCr 
Tau/TCr 
Ino/TCr 
Prost ca 
46 
15 
56 
106 
65 
67 
512 
574 
(n = 4) 
(25) 
(18) 
(82) 
(161) 
(39) 
(31) 
(368) 
(175) 
BPH 
24 
154 
182 
759 
25 
18 
197 
649 
(n = 7) 
(5) 
(36) 
(108) 
(408) 
(6) 
(5) 
(13) 
(57) 
N P ( n = l ) 
18 
308 
263 
209 
39 
25 
291 
704 
Ρ 
ρ < 0.05 
ρ < 0.05 
ns 
ρ < 0.05 
ρ < 0.05 
ρ < 0.05 
ns 
ns 
Relative integrals ol peak area's of metabolites of interest are listed as ratios lo lactate or 
total creatine The ratios of metabolites of interest are listed as mean with standard 
deviation between brackets Ρ values relate to a comparison between prostate 
adenocarcinoma and BPH 
Table 1 lists relative peak area integral ratios involving the doublet of the CH3 group 
of lactate at 1 33 ppm, the doublet of the CH3 group of alanine at 1.49 ppm, the 
quartet of the CH2 group ot citrate at 2.54 ppm, the singlet of the CH3 groups of 
(phospho)creatine at 3.04/3 05 ppm), the singlets of the CH3 group of 
phosphocholine and choline at 3.23 and 3.22 ppm respectively, the triplet of the CH2 
group of taurine 3.42 ppm and the triplet of the С Η group of inositol at 3.63 ppm. 
In figure 3 representative Ή MRS spectra are shown ot PCA extracts of NP (C), BPH 
(В) and prostate cancer tissue (Α) Ή MRS spectra of BPH and the NP tissue PCA 
extracts were comparable for most ratios whereas the Ή MRS spectra of BPH showed 
marked differences in the relative peak ratios as compared to the 'H MRS spectra of 
the prostate adenocarcinomas. Most striking is the presence of citrate in the spectra of 
the BPH specimens and the very low or undetectable levels in the specimens of 
advanced prostate carcinoma (table 1. ρ < 0 05) In one of the two cases where 
citrate could be detected, normal epithelial structures were seen. In contrast, no citrate 
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was observed in the prostate carcinoma biopsies containing no normal epithelial 
structures. In addition, a significant difference of the Ala / TCr, PC / TCr and 
Choi / TCr ratios between BPH and prostate cancer samples was observed (table 1., 
ρ < 0.05). 
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Figure 3. Representative in vitro Ή MRS spectra of PCA extract of adenocarcinoma of the 
prostate (A), benign prostatic hyperplasia (B) and normal prostatic tissue (C) 
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Ρ Magnetic Resonance Spectroscopy 
Figure 4 shows a 1 1P MRS spectrum of a PCA extract of normal prostate tissue. 1 [ P 
MRS resonances were assigned to phosphorylated compounds based on literature 
data.1 4 5 7 Several phosphomonoester peaks, e.g. phosphoethanolamine (PE) and 
phosphocholine (PC), and phosphodiester peaks, e.g glycerophospho-ethanolamine 
(GPE) and glycerophosphocholine (GPC), as well as a, II, and γ signals from 
different nucleoside triphosphate (NTP) peaks and inorganic phosphate (Pi) and 
phosphocreatine were identified and are indicated in figure 4. In table 2 ratios of 
phosphor metabolites compared to resonance integrals of total phosphate in the λ 1Ρ 
MRS spectra of the samples are presented. In figure 5 representative MP MRS spectra 
are shown of PCA extracts of NP (C), BPH (В) and prostate cancer tissue (A). As for 
the 'H MRS spectra, the M P MRS spectra of BPH specimens were comparable to the 
υ
Ρ spectrum of the NP sample. The significantly increased PC / TCr ratio in the 
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prostate cancer samples observed in the Ή spectra was also reflected in the 1 ! P spectra 
where the PC / TP was significantly higher in adenocarcinoma specimens of the 
prostate as compared to BPH (Table 2 , Ρ < 0 01) Also the GPE / T P ratio was 
Mgnificantly higher in the adenocarcinoma samples as compared to the BPH (Table 2 , 
Ρ < 0 05) In contrast, the ielative level of the other main phospholipid PE, was 
significantly lower in adenocarcinoma of the prostate as compared to BPH (Table 2 , 
Ρ < 0 05) 
Table 2. MP MRS relative peak integral ratios of prostatic human tissue 
tissue 
PE/TP 
PC/TP 
Pi/TP 
GPE/TP 
GPC/TP 
PCr/TP 
Prost Ca 
127 
63 
342 
37 
25 
21 
(n = 4) 
(43) 
(16) 
(80) 
(20) 
(16) 
(26) 
BPH 
186 
38 
282 
11 
12 
43 
(n = 7) 
(30) 
(4) 
(87) 
(5) 
(3) 
(17) 
NP(n = 
162 
38 
223 
9 
9 
39 
1) 
Ρ 
ρ < 005 
ρ < 005 
ns 
ρ < 005 
ns 
ns 
Relative integrals of peak area s ot metabolites of interest are listed as ratios to the 
total phosphate content (TP) The ratios of metabolites of interest are listed as mean 
with standard deviation between brackets Ρ values relate to a comparison between 
prostate adenocarcinoma and DPI1 
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Figure 4. In vitro "Ρ NMR spectrum of a PCA extract of normal prostatic tissue Peak 
assignments are indicated 
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DISCUSSION 
The first aim ot this study was ю characterize the metabolic content of human prostate 
specimens by Ή and " P MRS Thereafter we investigated whether differences in 
relative levels of metabolites in the Ή and M? MRS spectra could distinguish between 
different prostate pathologies ι e , between BPH and adenocarcinoma of the prostate 
We have chosen for an in vitro MRS study of PCA extracts of representative tissue 
samples thereby assuring proper detection and quantification of tissue metabolites 
Relative little tissue is needed to acquire an adequate signal / noise ratio and we 
assume that our results are well approximated reflections of the in vivo conditions 
because only transurethral resection material with a total ischemia time of less than 30 
seconds was included in this study In comparison to most other in vitro studies the 
sampling of the specimens was substantially shortened avoiding possible sampling 
artifacts, due to degradation of metabolites and ischemia 4 6 8 2 '7 4 
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Figure 5. Representative in vitro "P MRS spectra of PCA extracts of adeno carcinoma of the 
prostate (A) benign prostatic hyperplasia (B) and normal prostatic tissue (C) 
'H- and MP are the most used nuclei in in vivo MRS practice The use of Ή MRS 
seems most favourable because it has a much higher relative sensitivity compared with 
" P MRS However, the large number of proton containing metabolites may result in 
complex spectra, whereas 1 1P MRS spectra are relatively easy to acquire and interpret 
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Finally, Ή MRS provides information about proton containing compounds such as 
organic acids, amino acids and sugars whereas 1 ]P MRS finds its application in studies 
about high energy phosphate and phospholipid metabolism 
For most metabolite signal ratios evaluated in this study the Ή and Ή Ρ MRS spectra 
of the single NP specimen and the BPH samples were comparable In contrast several 
striking differences were observed between the MRS spectra of BPH and 
adenocarcinoma specimens of the prostate The Cit / Lac and Cit / total choline ratios 
were found to be potential markers in the discrimination of benign and malignant 
prostatic tissue (p<0 05) These ratios may be used in in vivo MRS of the prostate 
because the corresponding metabolite signals can be easily identified in these spectra 
(A Heerschap, unpublished data) Our MRS results, with respect to citrate and 
lactate, are in accordance with those obtained by others employing different 
techniques 11 л о g 1 Similar observations for citrate were made by Fowler et a l , 
employing Ή MRS, on the basis of other ratios 46 Recently, Kurhanewicz et al 
demonstrated that the citrate concentration of prostate adenocarcinomas was ten lold 
lower relative to normal and benign hyperplastic prostatic tissues K: 
It is assumed that in the normal prostate epithelial cells little citrate oxidation occurs 
and that the high level of cytosohc citrate inhibits glycolysis at the pyruvate 
Phosphokinase step Ί' Costello et al postulated that the oxidation of citrate is increased 
in prostate cancer cells resulting in a decreased cellular citrate concentration and 
increased glycolysis ' This hypothesis fits well with our observation that the Cit / Lac 
ratio was significantly decreased in the prostate cancer samples as compared to BPH 
Moreover our results support the early notion of Cooper et al that the Lac / Cit ratio 
may be used to discriminate malignant from benign prostatic tissue ^ 
Our results suggest a correlation between the relative amount of citrate and the 
percentage of normal epithelial structures seen in the PCA extracted specimens In 
cancer samples devoid of non-malignant epithelial structures no citrate could be 
detected by Ή MRS whereas the cancer sample with 5% normal epithelial structures 
showed the highest relative level of citrate of all samples The effect of tissue 
heterogeneity on citrate levels has also been observed by Schlieber et al but tor 
adenocarcinoma changes in the low percentage of glands did not have a major effect 
on citrate levels N S 
In the prostate cancer specimens the relative amounts of PC, Choi, and GPE, all cell 
membrane components, were significantly increased as compared to BPH All our 
patients had a high stage / grade of prostate cancer which have higher proliferation 
rates than surrounding normal tissues The increase of these metabolites may therefore 
be associated with an increase in membrane synthesis 22 32 lA1 
The relative level of PE was significantly lower for the prostate cancer samples For 
other cancers it has been suggested that an increase of the PE / PC ratio could serve 
as a marker tor malignancy u " However, the decreased PE / PC ratio that we 
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observed illustrates that this is not a general phenomenon l42 Daly et al showed that 
the PC content of cancer cells growing in choline enriched medium will increase with 
concurrent increase of GPC and GPE 12 Moreover, choline can inhibit 
ethanolammokinase, and thus blocking the PE producing step, if a sufficient 
intracellular concentration can be reached 32 Our observations of a relative increase of 
PC and GPE and decrease of PE fits well with the proposed pathway 
In conclusion, we characterized the major metabolic components ot prostate tissue 
employing proton and phosphorus MRS Significant differences in the metabolic state 
ot BPH and prostate cancers were found 
Several metabolic ratios, e g Cit / Lac, Cit / TChol, PC / TCr and Choi / TCr 
seemed to be potential markers to differentiate prostate cancer from BPH and these 
may be useful in the evaluation of in vivo MRS spectra of the prostate In our ongoing 
in vivo MRS study of the prostate, using transrectal coils, the Cit / TChol ratio indeed 
seems to be useful in discriminating BPH from adenocarcinoma ot the prostate 62 
Whether MRS spectroscopy can aid in the diagnosis and in therapy-monitoring of 
prostate cancer patients remains to be investigated "" 
Chapter 3 
MAGNETIC RESONANCE SPECTROSCOPY 
DETECTS METABOLIC DIFFERENCES 
BETWEEN SEVEN DUNNING RAT 
PROSTATE TUMOR SUBLINES WITH 
DIFFERENT BIOLOGICAL BEHAVIOUR. 
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INTRODUCTION 
With an estimated death rate of 34.000 cases in the USA in 1992, prostate cancer 
ranks second among cancer ι elated deaths in males alter lung cancer." Moreover, 
prostate cancer has become the most diagnosed malignancy in USA males m 1992." 
Unknown natural history, variable pathology and biological behaviour make prostate 
cancer difficult to classify into diagnostic and prognostic categories. Patients diagnosed 
with prostate cancer can be cured if the disease is at an early stage, i e patients with 
localized lesions can be cured by radical prostatectomy or radiotherapy. However, 
many patients will show clinical progression to metastatic disease. These are the 
patients that may benefit from aggressive treatments while in other patients, where the 
tumor will remain localized, no or less aggressive therapy may be given. Therefore, 
new diagnostic methods able to predict more accurately the biological behaviour of the 
tumor are needed since these may lead to a better base for individual treatment. 
One approach to solve (his problem is to investigate whether the metabolic profiles of 
prostate cancers differ significantly with respect to several tumor biological 
characteristics Magnetic resonance spectroscopy (MRS) has been introduced lor non­
invasive metabolic studies of cancer cells and for in vivo studies or tumors in animals 
and humans. For several cancers, it has been investigated whether MRS can be used 
to characterize differentiation grade, metastatic capacity, multi-drug resistance and 
hormonal dependency.'" :i 2A12 •"'·"· ^  7-<4" >" ' " ">'"7J For prostate cancer there is still a 
paucity ot knowledge to what extent tumors differ in their biochemical state. Vigneron 
and associates demonstrated that the phosphocreatine / adenosinetnphosphate ratio was 
significantly decreased in one hormone dependent Dunning subline compared lo a 
hormone insensitive one."''' It has been suggested that the relative amount ot citrate in 
the human prostate decreases in cancer tissue related to tumor differentiation.'" 
However, a recent in vitro 'H MRS study of extracts of surgical specimens by Fowler 
and coworkers did not show any correlation between Gleason grade and citrate."6 
The current study was designed to characterize the metabolic state of seven different 
Dunning R-3327 rat prostate tumor sublines employing both Ή Ρ and 'H MRS. We 
have chosen the Dunning tumor model system because the sublines differ widely in 
their histology, growth rate, androgen sensitivity and metastatic capacity, and 
therefore constitutes an appropriate tumor model system to test the hypothesis that 
differences in the metabolic content ot sublines can be related to their different tumor 
biological potential. Considering the complexity that can be expected for in vivo 
spectra, we decided to start with an analysis of in vitro perchloric acid (PCA) extracts 
of the Dunning tumors. In this way assignments of resonances in the spectra are 
facilitated and potential differences may be revealed more easily. 
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MATERIALS AND METHODS 
Animals 
Adult male Fl hybrid rats (F344CopFl/OLA/HSD, Copenhagen male and Fisher 
temale) were purchased from Harlan OL AC, Bicester, England The Fisher-
Copenhagen rats were housed three animals per cage and subjected to a 12 hours cycle 
light / darkness They were provided with a standard pelleted diet (Hope Farms, 
Woerden The Netherlands) and acidified water (pH 3) ad libitum 
Tumor Lines 
Six well-characterized sublines ot the Dunning R-3327 tumor were kindly provided by 
Dr J Τ Isaacs (Johns Hopkins Oncology Center, Baltimore, USA) 7" The AT-6 
subline was established in our own laboratory "• The characteristics of the H-, PIF-, 
PAP , G , AT-2-, AT-6 and MatLyLu sublines(MLL) are summarized in table 1 The 
tumors were transplanted subcutaneously in the tlank of Fisher-Copenhagen rats as 
trocar pieces Tumors were allowed to grow to a tumor volume ot 1000-1500 mm1 
Two different passages (except for the H subline) of each subline were investigated 
Table 1. In vivo biological characteristics of Dunning R-3327 rat prostate cancer 
Dunning 
Subline 
Histology Growth rate 
(Doubling time 
in days 
Androgen Metas 
responsive Ability 
H 
PAP 
PIF 
G 
AT-2 
AT-6 
MLL 
Well diff 
Well diff 
Poorly diff 
Anaplastic 
Anaplastic 
Anaplastic 
Anaplastic 
22 0 
10 5 
3 7 
4 0 
2 5 
4 0 
1 5 
+ 
± 
± 
± 
± 
± 
+ 
5 0 
2 0 
1 1 
0 2 
0 2 
1 0 
0 1 
Yes 
Yes 
No 
Yes 
No 
No 
No 
Low 
Low 
Low 
Low 
Moderate 
High 
High 
Preparation of PCA tissue extracts 
PCA extraction was performed as described earlier by Smits et al l 5 5 In short, frozen 
tissue was weighed and pulverized at 80 ° C, transferred into an all glass 
homogenizer and 0 9 M PCA was added dropwise to a total of five times the weight 
ot the tumor sample Complete tissue homogenization was achieved in approximately 
30 minutes 
Alter centrifugation (12,000 g, 15', 4° C) ot the tissue homogenates, the pellet was 
discarded and the pH of the supernatant was immediately adjusted to 7 5 with 9 M 
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КОН. The PCA precipitate was centrifugea (12,000 g, 15', 4° С) and the supernatant 
was passed through a Chelex sample preparation disc (Bio-Rad Laboraties, Richmond, 
USA) and lyophilized. Lyophilizates were stored at - 20° C. Thirty percent of the 
lyophihzate was used for Ή MRS and 70 % for Ί1Ρ MRS. 
Before the 'H MRS measurements, the lyophilizates were carefully thawed and 
dissolved in 500 μ\ 20 mM potassiumphosphate buffer pH 7.0. If necessary the pH 
was adjusted to pH 6.9-7.1 Thereafter the samples were lyophilized and dissolved in 
500 μ\ D 2 0 with 1.6 mM 3-(Trimethylsilyl) propionic acid-d4 sodium salt (TSP). 
For the q 'P MRS measurements the lyophilizate was dissolved in 450 μΙ 0.5 mM 
dimethylphosphate, 20mM EDTA, 10 mM Tris, pH 7 8 in 30% D20. 
1 1
Ρ MRS measurements 
The 1 ] P MRS spectra were acquired on a 200 MHz spectrometer (Bruker WM200) and 
were recorded with a standard 5 mm 1 ] P MRS high resolution probe employing a 50° 
flip angle and a pulse repetition time of 4 sec. WALTZ-16 low power broadband Ή 
decoupling was used during data acquisition. The PCA extracts were analyzed under 
spinning conditions with a linewidth of the H 2 0 signal between 1 and 3 Hz. The 
chemical shifts were referenced with respect to the chemical shift position of the 
phosphocreatine resonance. 
The MRS data were further evaluated employing the NMR1 package (New Methods 
Research, INC, Last Syracuse, NY, USA) on a SUN Sparc station 330 (Sun 
Microsystems, INC, Mountain View, USA). FIDs were Fourier transformed and the 
phase was manually corrected. The ^'P MR spectra were semiautomati-cally fitted to 
Lorentzian hneshape model functions. To enable comparison of different spectra, 
relative integrals of phosphor metabolite resonances of interest were expressed as ratio 
to the total integral values of all phosphate signals (TP) in the sample. 
IH MRS measurements 
Ή MRS spectra were acquired on a 500 MHz spectrometer (Bruker AM500) and 
were recorded with a standard 5 mm Ή MRS probe, employing a 45° flip angle and a 
7.3 pulse repetition time. The resonance of H20 was suppressed by low power 
continuous wave presaturation. 
The chemical shifts were referenced with respect to the chemical shift position of the 
TSP resonance. Ή MRS spectra were evaluated with NMR1 software. FIDs were 
Fourier transformed after zero-filling from 8 К to 32 К and Lorentzian to Gaussian 
translormation. The phase was manually corrected and the spectra were 
semiautomatically fitted to Gaussian hneshape model functions. To enable comparison 
of different spectra, relative integrals of proton metabolite resonances of interest were 
expressed as ratio to the total amount of the relative integral of total creatine TCr (this 
consists of creatine and phosphocreatine). Total creatine levels appear relatively stable 
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during hypoxia and prolonged ischemia7'""', but may differ as a function of muscular 
content or tumor tissue in the biopsy 
Statistical analysis 
Differences in ratios of metabolites between the well and moderately differentiated 
rumors (N = 6) and poorly differentiated and anaplastic (N = 8), the non-metastatic 
(N = 8) and metastatic (N = 6) sublines, and the hormone dependent (N = 6) and 
hormone independent (N = 8) sublines groups were investigated by the Kruskal-Wallis 
test at an experimental error rale of 0 05 
RESULTS 
MR spectra of PCA extracts of seven Dunning R-3327 sublines were recorded and for 
each subline, except for the H tumor, two different passages were investigated 
For correlative studies between metabolic profiles and rumor biological characteristics, 
the sublines were grouped according to histology, metastatic capacity or androgen 
responsiveness It must be emphasized that these groups are partly overlapping, e g 
well and moderately differentiated (H, PAP and PIF) versus poorly differentiated and 
anaplastic (G, AT 2, AT-6 and MLL), metastatic (AT-2, AT-6 and MLL) versus non-
metastatic (H, PAP, PIF and G) whereas hormonal responsive versus hormonal non-
responsive were H, PAP and G versus PIF, AT-2, AT-6 and MLL 
3 1
Ρ magnetic resonance spectroscopy 
Figure 1 shows Ή Ρ MRS spectra of extracts of the Η and MLL Dunning tumor 
sublines Resonances in the spectra were assigned to the phosphomonoesters, 
phosphoethanolamine (PE) and phosphochohne (PC), which primarily function as 
precursors of phospholipid biosynthesis and to the phosphodiesters, glycero-
phosphorylglycerol (GPG), glycerophosphoethanolamme (GPE) and glycero-
phosphocholine (GPC), which are phospholipid catabolites 12 Not only these 
phosphomono and phosphodiester resonances but also cyclic sugar phosphates (C-sp), 
inorganic phosphate (Pi), PCr as well as alpha, beta and gamma signals from different 
nucleoside tn phosphate (NTP) peaks could be identified using literature data 14 57 
Ratios of phosphor metabolites were obtained of 3 I P MR spectra from all sublines 
investigated 
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Figure 1. In vitro "P MR spectrum with peak assignments ot PCA extract of parental Η Dunning 
R-3327 tumor (A) and MaiLyLu Dunning R-3327 tumor (B) 
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Figure 2. Ratios of integrals ot "P MRS metabolites for A well to moderately differentiated 
Dunning tumor sublines (open triangle) compared with poorly differentiated or anaplastic sublines 
(closed triangle) B: metastatic (closed square) versus non metastatic (open square) sublines and 
С androgen responsive (closed circle) versus non responsive (open circle) Values are median 
with range (mm and max value) 
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Several ol these ratios obtained tor the well and moderately differentiated sublines (H, 
PAP and PIF) diftered trom the poorly differentiated and anaplastic sublines (G, AT-
2, AT-6 and MLL) The PC, GPE, GPC and PCr ratios were significantly higher for 
the well and moderately differentiated lines (Fig 2A) The PC / TP ratio was also 
significantly increased when the low metastatic sublines H, PAP, PIF and G were 
compared to the moderately and highly metastatic AT-2, AT-6 and MLL (Fig. 2B). 
All metastatic Dunning sublines contained GPG. The GPG resonance peak was also 
seen in the parental H subline, but at much lower relative intensity (Fig 1) With 
respect to androgen responsiveness, the PC / TP ratio was significantly decreased in 
(he androgen non-responsive PIF, AT-2, AT-6, and MLL sublines (Fig 2C) 
IH magnetic resonance spectroscopy 
A 500 MHz proton NMR spectrum of a PCA extract of the H and MLL sublines, with 
two expanded parts, is shown in figures 3 and 4 respectively Numerous resonances 
can be distinguished in the spectrum In part, these resonances could be identified with 
data trom the literature 2 S 4 " 1 2 4 For each compound investigated in this study the best 
resolved resonance(s) were selected for quantitation 
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Figure 3. In viiro Ή MR spectrum with peak assignments of PCA extract of parental Η Dunning 
R-3327 tumor 
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Figure 4. In vitro Ή MR spectrum of РСЛ extract of MatLyLu Dunning R-3327 tumor 
Relative peak area integral ratios involving the doublet of the CH3 group ot lactate 
(Lac) at 1 33 ppm, doublet ol the CH3 group of alanine (Ala) at 1 49 ppm, quartet ot 
the CH2 group ol citrate (Cit) at 2.54 ppm, singlet of the CH3 group ol 
(phospho)creatine at 3.04/3 05 ppm), singlets of the CH3 group ot phosphocholine 
(PC) and choline (Choi) at 3 23 and 3.22 ppm respectively, triplet of the CH2 group 
of taurine (Tau) 3 42 ppm and triplet ot the CH group ot inositol (Ino) at 3 63 ppm 
The PC resonance may also contain a contribution of GPC protons. 
Remarkably, inositol could only be detected in the well and moderately differentiated 
sublines H, PAP and PIF, but not in the poorly differentiated and anaplastic sublines 
G, AT-2, AT-6 and MLL (Fig 5A). The Ino / TCr ratio was not only significantly 
increased when the well and moderately sublines were compared with the poorly 
diffeientiated and anaplastic ones but also the non-metastatic sublines H, PAP, PIF 
and G differed from the metastatic sublines regarding the Ino / TCr ratio (Fig. 5B and 
5C) The significantly increased relative PC levels of the well or moderately 
differentiated, non-metastatic and andiogen dependent sublines with respect to the 
poorly differentiated or anaplastic, metastatic and androgen independent sublines 
observed in the M P spectra (see above) was also observed in the Ή MR spectra, ι e 
the PC/TCr ratio was significantly higher for the same groups ot sublines (Fig 5A-C). 
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This was also found (or the total choline (choline + phosphocholine) ratio For as 
well the PC / TCr as the Tchol / TCr ratio a significantly increase was found 
(p<0 05 tor TChol / TCr lor all groups, results not shown) Citrate resonances were 
absent or extreme low in the Ή MR spectra ot all Dunning sublines investigated Ή 
MR spectra ol extracts ot normal prostate of Fisher-Copenhagen rats does contain 
signals tor citrate (results not shown) 
Figure 5. Ratios of integrals ot Ή MRS metabolites for A well to moderately differentiated 
Dunning tumor sublines (open triangle) compared with poorly differentiated or anaplastic sublines 
(closed triangle) B: metastatic (closed square) versus non-metastatic (open square) sublines and 
С androgen responsive (closed circle) versus non responsive (open circle) Values are median 
with range (mm and max value) 
DISCUSSION 
Tumors of the seven Dunning sublines used in this study range from well 
differentiated to anaplastic are androgen dependent or independent and differ in their 
metastatic ability (table 1) The aim of this investigation was to characterize the 
metabolic profile of these Dunning R 3327 rat prostate cancer sublines as viewed by 
Ή and Ή Ρ MRS Thus we wanted to identify variations in their biochemical content 
which might be related to differences in biological behaviour By analyzing PCA 
extracts, several well resolved resonances were identified which gave us the oppor­
tunity to quantify some main biochemical components in rat prostatic cancer tissue 
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The main metabolites deteeted with Ή Ρ and Ή MRS in the Dunning tumors were 
similar to those observed in our earlier study in which human prostate samples were 
investigated.25 Several metabolic ratios appeared to be valuable for the evaluation of 
sublines clustered for one specific biological characteristic. 
Differentiation grade 
The relative levels of phosphocholine, glycerophosphocholine and glycero-
phosphoethanolamine were found to discriminate between well (or moderately) 
differentiated and anaplastic or poorly differentiated tumor sublines. As 
phosphocholine levels also correlated with metastatic potential and androgen 
insensitivity, this marker is not specific for differentiation alone. The for in vivo 
MRS more important relative level of total choline (choline + phosphocholine) was 
also increased for these three biological characteristics. Thus these markers may be 
useful to identify an aggressive subpopulation of prostate cancer tumor cells. 
A relation between differentiation grade and phospholipid metabolism has been 
suggested for several other tumors.2 ' * " Agris and Campbell showed with the help of 
Ή NMR an enhanced accumulation of PC during dimeihylsulfoxide induced 
differentiation of Friend Leukaemia cells.2 In the same model Carpinelli et al. found 
with " P MRS an increase in PC and a concomitant decrease of GPC and GPE 
levels."1 Galons and associates used a human colon adenocarcinoma model and also 
showed with " P and 'H MRS high levels of PC and choline after inducing 
differentiation." These observations together with our findings clearly demonstrate 
that alterations in the phospholipid metabolism plays a role in the process of 
differentiation although changes may occur at different levels in the phospholipid 
metabolism for tumors of different origin. An increased PC content may have several 
different causes: increased phospholipid synthesis, enhancement of Phosphokinase 
activity, inhibition of the cytidylyltransferase activity or an increment in the pool of 
intracellular choline.1* Further alterations in the phospholipid metabolism found in the 
Dunning tumor model system may be explained by the fact that increased PC content 
leads to a increase of GPE and GPC due to inhibition of GPE diesterase.412 
The well differentiated H- and PAP sublines and the moderately differentiated PIF 
subline contain high levels of inositol, whereas this compound was not detectable in 
the other sublines. Apparently inositol metabolism in the anaplastic rat prostate tumors 
differs substantially from that in the well differentiated prostate tumors. 
The biochemical role of inositol is not well known.14" It is a requirement for the 
growth of mammalian cells. It may be a "storage" form for phosphorylated inositols, 
of which some have a function as intracellular messengers, or for glucose and in 
addition may have a role as an osmoregulator. As yet it is unclear why the content of 
inositol in non-differentiated tumor cells is reduced. Any of its potential functions may 
be involved. 
The relative content of PCr also correlated with differentiation grade. The reduced 
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PCr levels tor the anaplastic and poorly dilterentiated sublines are indicative tor a 
poorer high energy phosphate metabolism Previously, the relative amount ot PCr has 
been indicated as a marker tor the hormonal dependency ot the several tumors 117 "'" 
Metastatic ability 
11
Ρ MR spectra ot the highly metastatic MLL and AT-6 sublines and the moderately 
metastatic AT-2 subline showed a small but significant peak at 3 9 ppm We have 
assigned this peak to GPG which is probably a degradation compound ot a 
phospholipid produced by a phosphohpase A '4 GPG may be a marker tor metastatic 
capacity however this peak was also found in one of the slowly growing, low-
metastatic parental Η tumors 
Due to the overlap of groups also the Ino / TCr ratio appeared to be significantly 
different in the non-metastatic sublines versus the metastatic ones, but regarding the 
very strong relation with histology the specificity of this finding is questionable 
Although, as for choline and phosphochohne, inositol can be a potential general 
marker tor an aggressive subpopulation of prostate cancer cells 
Androgen responsiveness 
Several studies have suggested that 1 ! P MRS can be helpful in distinguishing hormone 
sensitive from hormone insensitive cancers '^7"'' In particular an increased PCr / ATP 
ratio was found in a hormone sensitive Dunning tumor subline when compared to a 
hormone insensitive tumorline " ' Androgen deprivation (orchiectomy) resulted in a 
significant decrease in the PCr / ATP ratio In this in vivo study only one subline with 
this particular tumor biological characteristic was investigated In the present in vitro 
study, three different hormone sensitive and tour different hormone insensitive 
sublines were investigated and no specific correlation for hormonal sensitivity with the 
metabolites examined in this study could be made neither by 1 ]P - nor by 'H MRS 
Only the two PAP tumors showed a higher PCr / TP ratio then hormone insensitive 
sublines but for the other two hormone sensitive lines the same increase was not 
observed 
Citrate levels 
Previous studies have observed very low or undetectable levels of citrate in prostate 
cancer tissue / cells compared to benign prostatic hyperplasia, probably due to an 
altered citrate metabolism 2< 4Ч K u<; In the present study we could not detect citrate 
signals in the spectra ot the Dunning sublines which may seem to fit well with these 
findings for human prostate tissue However, the original parental Η tumor was 
derived trom the dorsal prostate of the rat which does not contain citrate producing 
glands Ή 1 ,я Therefore the absence ot citrate in all Dunning tumors is not surprising 
and in these cases not indicative tor prostate cancer tissue 
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Conclusions 
The present findings show that in the Dunning R-3327 tumor model, well 
differentiated, non metastatic and hormone dependent tumors can be distinguished 
from anaplastic or poorly differentiated, metastatic and hormone independent tumors 
with the help of ? IP and Ή MRS. Moreover, some metabolic ratios may be more 
specific markers for differentiation grade or metastatic capacity alone. Although it is 
difficult to extrapolate animal data to the human situation, these in vitro findings may 
give a lead for the in vivo studies on human prostate cancers. 
Chapter 4 
IN VITRO PROTON MAGNETIC RESONANCE 
SPECTROSCOPY OF FOUR HUMAN PROSTATE 
CANCER CELL LINES 
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INTRODUCTION 
The recent development and clinical introduction of transrectal probes not only 
improved the quality of magnetic resonance imaging (MRI) of the human prostate but 
also made this organ accessible to magnetic resonance spectroscopy (MRS) "^ " " I 4 7 1 4 f l 
Transrectal MRI and MRS, basically employing the same instrumental set-up, are 
potential powerlul non-invasive methods for monitoring the diseased prostate First to 
identity with MRI the suspected lesion and secondly to monitor with MRS the 
metabolism of this lesion Changes in various metabolic pathways associated with 
several cancers have been reported" 0 1 4 1 1 4 2 For prostate cancer, metabolic 
derangements might provide markers that improve diagnosis and allow more accurate 
prediction of its clinical behaviour In vitro and in vivo studies employing 1 1P, Ή and 
n C MRS have shown that differences in the metabolic content of human piostate 
tissue samples correlated with tumor grade , , 4 h " 2 1 0 5 1 ( l 7 '•" 1 4 f > 1 5 1 IU Moreover, for the 
Dunning R 3327 rat tumor model it has been demonstrated that the relative levels of 
phosphocreatine, glycerophosphorylglycerol, glycerophosphoethanolamine and 
glycerophosphochohne, obtained by Ή and Ή Ρ MRS, can be used to differentiate 
sublines by differentiation grade, androgen sensitivity and metastatic capacity 1? l 6 ' 
However, interpretations of dillerences in MRS spectra between human prostate 
tissues with different biological behaviour are hampered by tissue heterogeneity and 
the lack of a complete understanding of the biochemical pathways MRS examinations 
of well defined human model systems are therefore needed to allow correlations 
between metabolic patterns and biological behaviour For this reason, studies of 
human prostate (cancer) cell strains are of value Yacoe et al investigated cell strains 
derived from human prostates to investigate whether 'H MRS could reliably 
distinguish normal prostate epithelium from prostate cancer , 7 4 In the present study we 
attempted to identify differences in metabolites which correlated with dillerent 
biological behaviour, e g androgen responsiveness and morphology, in human 
prostate cancer Four well established human prostate cancer cell lines were 
characterized with in vitro proton MRS and metabolic differences were correlated with 
their biological behaviour 
Materials and Methods 
Tumor Cell Lines 
Four established human prostatic carcinoma cell lines, PC-3, DU 145, TSU-Prl and 
LNCaP were used in this study ' , 6 6 9 7 1 " 4 The characteristics of the four cell lines are 
summarized in table 1 Cells were maintained in RPMI 1640 culture medium supple 
mented with 10% foetal calf serum, 2 mM L-glutamine, 100 IU/ml penicillin, 100 
Aig/ml streptomycin and 250 nM dexamethasone at 37°C in 6% C0 2 at 99% relative 
humidity 
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Table 1. Characteristics of the tour human prostate cancer cell lines used 
Cell line Origin Histology of Doubling time Androgen PSA 
ong tumor (hours) respons producing 
LNCaP66 
DU-1451M 
PC-372 
TSU-PR164 
Lymphnode moderate 
Brain poorly 
Bone poorly 
Lymphnode poorly 
50 1 ± 8 0 
28 7 ± 2 9 
35 2 ± 6.7 
26 4 + 4 5 
+ 
Preparation of tissue extracts 
After reaching a confluency of 70-80%, cells were harvested for perchloric acid 
(PCA) extraction as described previously 25 In short, single cell suspensions were 
obtained by trypsinization (0 25% trypsin/0 1% EDTA) and immediately washed three 
times with ice cold 0 9% NaCl to remove all the medium components The total 
number of cells varied between 4 6 χ IO6 cells Viability, as determined by the trypan 
blue dye exclusion test, was always > 95% After centnfugation of the single cell 
suspension, the cell pellet was frozen in liquid nitrogen and stored at -80CC until time 
of extraction 
The cell pellet was transferred into an all glass homogenizer and 4 ml ice cold 0 25 M 
PCA was added dropwise Cell homogenization was achieved at -80°C in 
approximately 30 minutes After centnfugation (12,000 g, 15 min, 4° С) of the cell 
extract, the pellet was discarded and the pH of the supernatant was immediately 
adjusted to 7 5 with 2 5 M КОН The PCA precipitate was centrifuged (12,000 g, 15 
mm, 4° C) and the supernatant was passed through a Chelex sample preparation disc 
(Bio-Rad Laboraties, Richmond, USA) and lyophilized Lyophilizates were dissolved 
in 500 μΐ 40 raM potassiumphosphate pH 7 0 The pH was corrected to pH 6 90-7 10 
if necessary by addition of HCl or KOH The samples were lyophilizated again and 
stored at - 20° С 
3 ml samples of culture media of all prostate cancer cell lines investigated was 
lyophilizated and stored at 20° С 
Just before the Ή MRS measurements, the lyophilizate was carefully thawed and 
dissolved in 500 μ\ D20 containing 1 6 mM 3-(Tnmethylsilyl) propionic acid-d4 
sodium salt (TSP) 
Ή NMR measurements 
Ή NMR spectra were acquired on a 500 MHz spectrometer (Bruker AM500) and 
were recorded with a standard 5 mm Ή NMR probe The spectra were recorded 
employing a 45° dip angle (6 ^s) and a 7 28 sec pulse repetition time The resonance 
of H
:
0 was suppressed by low power continuous wave presaturation For the spectrum 
of each PCA extracted cell sample 900 scans were accumulated The chemical shifts 
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were referenced with respect to the chemical shift position of the TSP resonance. 
Ή NMR spectra were further evaluated employing the NMR1 package (New Methods 
Research, INC, Last Syracuse, NY, USA) on a SUN Sparc station 330 (Sun 
Microsystems, INC, Mountain View, USA). Free induction decays (FIDs) were 
Fourier transformed after zero-filling from 16 К to 32 К and the application of a 
Lorentzian to Gaussian transformation filter. The spectra were semi-automatically 
fitted to Gaussian lineshape model functions Relative resonance integrals of proton 
metabolites of interest are expressed as ratios to the integral resonance of TSP. 
Statistical analyses 
Differences in ratios of metabolites between the different cell lines were investigated 
by the Wilcoxons rank test. Due to multiple testing Ρ < 0.01 was considered as 
statistically significant. 
RESULTS 
PCA extracted cell lines 
MR spectra of PCA extracts of four human prostate cancer cell lines were recorded 
and tor each cell line at least five different passages were investigated. A 500 MHz 
proton MR spectrum of a PCA extract of the LNCaP cell line, with two expanded 
parts, is shown in figure 1. Resonances of some main metabolites could be identified 
with data from the literature.2,4° 
For each compound the best resolved resonance(s) were selected for quantitation 
purposes. Table 2 lists relative peak area integral ratios involving the doublet of the 
CH3 group of lactate (Lac) at 1.33 ppm, doublet of the CH3 group of alanine (Ala) 
at 1.49 ppm, quartet of the CH2 group of citrate (Cit) at 2.54 ppm, singlet of the 
CH3 group of (phospho)creatine at 3 04/3 05 ppm), singlets of the CH3 group of 
phosphocholine (PC) and choline (Choi) at 3.23 and 3 22 ppm respectively, triplet of 
Several differences were found between MRS spectra of the PCA extracted human cell 
lines. This is illustrated in figure 2 where 'H MRS spectra of one LNCaP (A) and one 
TSU PCA extract (B) are shown. 
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Figure l:In vitro Ή MR spectrum with peak assignments of PCA extract of LNCaP human 
prostate cancer cell line. 
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Figure 2.1n vitro 'II MR spectra of PCA extracts of LNCaP cell line (A) and TSU cell line 
(B). 
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The first prominent observation was the relative high amount of total creatine (TCr = 
PCr plus Cr) in the PCA extracts of LNCaP cells (table 2) The TCr / TPS ratio 
appeared to be significantly higher tor the LNCaP cells samples when compared with 
the other three cell lines (p<0 01) 
Secondly, citrate resonances were absent in the MR spectra of PCA extracts of the 
PC-3, DU-145 and TSU cell lines, whereas only in one of the five samples of the 
LNCaP cell line citrate could be detected in the MR spectra Since citrate can rapidly 
diffuse from the prostate cell into the culture media also all media were 
spectroscopically examined Ή MR spectra ot the culture media of the LNCaP cells 
showed citrate resonances whereas in all the media ot the other three cell lines no 
citrate resonances were detected (results not shown) 
Finally, several differences in metabolic content of PCA extracts of DU-145, TSU and 
PC-3 cells were found The relative amount of taurine was significantly higher for the 
DU-145 PCA cell extracts when compared with the PC-3 and TSU (all p < 0 01) PC 
3 and TSU cell extracts differed significantly from each other for inositol and creatine 
content, whereas the creatine content of DU-145 PCA extracts was also different from 
TSU PCA extracts (p<0 01, table 2 ) 
Table 2. Mean of metabolite ratios (range between brackets) of tour human prostate 
cancer cell lines 
LNCaP DU-145 TSU-PR1 PC-3 
lac/tsp 
Ala/tsp 
Citr/tsp 
Cr/tsp 
Chol/tsp 
PChol/tsp 
Ino/tsp 
Tau/tsp 
Gly/tsp 
94 
84 
0 
60 
40 
6 
0 
11 
48 
(18-169) 
(18-164) 
(0-72) 
(36-132) 
(18-69) 
(3-9) 
(0-140) 
(0-43) 
(0-107) 
34 
11 
0 
9 
12 
5 
156 
84 
7 
(11-67) 
(7-23) 
(2-11) 
(9-23) 
(4-9) 
(6-406) 
(20-224) 
(0-13) 
25 
6 
0 
0 
22 
4 
0 
0 
5 
(14-46) 
(4-19) 
(15-26) 
(0-7) 
(0-20) 
(0-5) 
(0-9) 
12 
5 
0 
10 
16 
3 
44 
0 
6 
(6-56) 
(1-9) 
(3-37) 
(7-56) 
(1-10) 
(21-53) 
(0-13) 
(3-10) 
DISCUSSION 
Prostate tumors present sharp interindividual variations in biological behaviour and 
response to therapy At least 20-25% of the patients where hormonal treatment is the 
first choice therapy will not react and an equal percentage becomes resistant to the 
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treatment within 2 years 1Ч 11s Therefore, new diagnostic methods able to predict more 
accurately the biological behaviour of the tumor are needed since these may lead to a 
better basis tor individual treatment 
We examined tour well characterized human prostate cancer cell lines with Ή MRS 
An in vitro approach was chosen because Ή MRS of biological material may produce 
complex spectra, which are difficult to resolve in vivo Assignments tor the same 
main metabolites were made as tound earlier tor human prostate cancer ^ 
In this panel of PCA extracted human prostate cancer cell lines the relative level ot 
total creatine was found to be discriminative for hormone sensitivity Vigneron et al 
tound by in vivo 1 1P MRS, an increased PCr / ATP ratio in one hormone sensitive 
Dunning tumor subline when compared to one hormone insensitive subline "''' 
Androgen deprivation (orchiectomy) resulted in a significant decrease of this ratio 164 
However, in a recent in vitro MRS study, where three different hormone sensitive and 
tour different hoi mone insensitive Dunning sublines were investigated no specific 
correlation tor hormonal sensitivity with relative metabolite levels, including the 
PCr / ATP ratio, could be made 27 A correlation of increased PCr concentration and 
hormone sensitivity has also been suggested for rat breast cancer m Creatine levels 
can presently be detected in Ή MR spectra recorded with transrectal probes, hence in 
vivo human MRS studies can now test the relevance ot these in vitro observations " 
Previous biochemical and MRS studies have suggested that the metabolism of citrate 
may be altered in prostate cancer 21 ls 2''4Ч 82 " l 4 s Citrate is a secretory product ot the 
prostate and its production and secretion are under androgenic control 2Ч Testosterone 
stimulates the net citrate production and might also play an role in the citrate 
secretion 29 Normally citrate is present in human prostate tissue in high 
concentrations212Ч w In culture however, citrate can rapidly diffuse from the prostate 
cell in the culture media 4Ч It is therefore obligatory to measure both citrate levels in 
prostate (cancers) cells and in their culture media in studies with cultured prostate 
(cancer) cells In the present study, citrate resonances were absent in the MR spectra 
ot PCA extracts of DU 145, PC-3 and TSU cells and in their culture media 
Kurhanewicz et al already showed that citrate signals could not be observed in Ή 
MR spectra of DU 145 xenografts, either in vivo or in PCA extracts "2 In contrast, in 
one of the five LNCaP extracts a MRS detectable level of citrate was found and all the 
media of LNCaP cells showed citrate resonances in the MR spectra, suggesting that 
the hormone dependent LNCaP cells have a higher relative level of citrate compared 
to the other three hormone insensitive cell lines Early studies already suggested that 
citrate is reduced in early prostate cancer and nearly absent in advanced disease, 
which are known to have only a small portion of hormone sensitive cells 2 1 2 " 9 1 
Possibly there is a difference in citrate content between hormone responsive and non-
responsive prostate cancers Our present finding seem to fit well with this hypothesis 
and the aforementioned studies However, further in vivo MRS studies should be 
performed to compare the citrate concentrations in tumors of patients which are 
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escaped from hormonal treatment versus patients which do respond well to validate 
this finding 
Finally, each prostate cancer cell line has its own metabolic fingerprint, e g several 
differences in metabolic content were found irrespective their biological behaviour 
The most striking difference was the high taurine content of the DU-145 cell extracts 
compared to both the PC-3 and the TSU cell extracts Kurhanewicz et al also showed 
large taurine resonances in the in vivo and m vitro Ή MRS spectra ot DU-145 tumor 
The difference in taurine content might be explained by differences in origin ot the 
metastasis 66 M 7 2 1 6 4 
In conclusion, this MRS study of PCA extracts of four human prostate cancer cell 
lines demonstrate that, although each cell line has it's own metabolic fingerprint, the 
creatine / tsp and citrate / tsp ratios can be used to discriminate the androgen 
dependent LNCaP cell line from the other androgen independent cell lines Clinical 
MRS studies with transrectal probes now have to be performed to determine whether 
it is possible to discriminate cancers which will respond to androgen therapy based on 
their relative citrate and creatine content 
Chapter 5 
EFFECTS OF HIGH ENERGY SHOCK WAVES ON 
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INTRODUCTION 
High energy shock waves (HESW) are of interest in the development of new 
experimental tumor treatment modalities Generated extracorporally and focused on a 
well-defined limited volume in the body, HESW can be used to influence rumor 
growth and response to therapy in vivo 1 4 1 7 6 7 l i n 142 Studies using tumor models in 
animals have shown that, at a constant acoustic energy output, HESW have a dose 
dependent tumor growth suppressive effect, whereas treatment with a higher number 
of HESW or with the same number at different time intervals results in a more 
prolonged tumor growth inhibition '21 '6Ч In addition, combination with chemo- or 
cytokine-therapy resulted in more pronounced and even synergistic anti-tumor 
effects 1 M 122 
As nuclear magnetic resonance spectroscopy (NMR) enables to monitor changes in 
tumor metabolism in a longitudinal way it is a suitable technique for the evaluation of 
tumor therapies , 6 Recently, using in vivo ""P NMR, we have shown that the 
administration of HESW, focused on the centre of NU-1 human kidney cancer 
xenografts resulted in a significant, dose dependent, temporary reduction in 
high-energy phosphates, concomitant with an increase in inorganic phosphate (Pi) 
levels and a decrease in intra-cellular pH These changes occurred immediately after 
HESW exposure and preceded the suppression of tumor growth ' " These metabolic 
changes are qualitatively similar to those produced by ischemic inhibition of energy 
metabolism and suggest functional vascular changes following HESW exposure 
Histological examinations in various tumor models clearly reveal structural 
abnormalities at a vascular level after HESW treatment and suggest that vascular 
damage in the tumor may be the primary cause in promoting tumor necrosis 1 4 " 1 2 1 
Thus, it is likely that the effects of HESW at the vascular level impair tumor cell 
metabolism 
In this study we tried to confirm the hypothesis that an important target of HESW 
involves the functionality of the vascular component of tumors Tumor blood flow 
(TBF) and perfusion can be measured directly by 2H NMR monitoring of D 20 applied 
to the tumor 4 1 7 6 77 
We have used this method to investigate the extent and duration of the effect of 
HESW on TBF After intra-tumoral injection ot D20 as a freely diffusible tracer, the 
clearance of 2HO'H was monitored By using mathematical (multi-)compartment 
models, this technique has shown to be a sensitive and reproducible method in the 
determination ot TBF and perfusion 42 76 " 
As a direct metabolic consequence of the reduced TBF and oxygenation an increase in 
anaerobic metabolism and lactate production is expected Therefore, we also estimated 
the tumor lactate concentrations by Ή NMR before and after HESW treatment In 
addition, the Ή NMR measurements were combined with 1 ! P NMR measurements in 
53 
order lo investigate the relation between lactate levels and pH as a function of time 
MATERIALS AND METHODS 
Animals 
Xenografts were transplanted in six to eight week old male BALB/c athymic mice 
(Bornholtgärt, Ry, Denmark) The mice were kept in groups of five in PAG type 2 
cages covered with an iso cap (Ufa Credo, France) for sterile conditions The mice 
were fed ad libitum with irradiated SRM-A MM food (Hope Farms, Woerden, The 
Netherlands) and drinking water was acidified (pH 3) 
Tumors 
The human renal cell carcinoma NU-1 xenograft was established in our laboratory by 
subcutaneous implantation of small tumor pieces derived from a tumor nephrectomy 
specimen Histologically the tumor is characterized as sarcomatous '2n For the HESW 
studies, tumors were implanted subcutaneously as trocar pieces at the upper part of the 
hind limb Passages 40-48 in vivo were used The three dimensions of the tumor were 
determined with a precision sliding calliper by measuring the maximum diameter and 
the diameters perpendicular to it The tumor volume was calculated by the equation 
(LxWxH) χ (π/6) As in our earlier NMR experiments, rumors were allowed to grow 
lo a volume of 250-300 mm1 (mean 275 mm3) 
HESW treatment 
The studies presented here were performed on a shock wave generator specially 
designed for experimental animal and in vitro studies The principles of the 
experimental set-up, the way of administration of the shock waves, and the positioning 
of the tumors in the focal area were described earlier in detail 121 
In contrast to those experiments, we now used an electromagnetic HESW generator 
modified from the clinical available Lithostar plus (Siemens) With this experimental 
generator higher pressure amplitudes can be obtained in a smaller focal area The 
physical principles and the definition of the parameters of its acoustic field were 
described elsewhere ' 2 J 1 6 6 Standardization and control of the acoustic field was assured 
by pressure measurements performed before each experiment Although the focus 
(defined by isobar lines representing 50% of the P
max
) is somewhat smaller, the total 
acoustic energy is equivalent to that ot the Lithostar and, assuming that the pressure 
profile and energy are the main determining factors, we compared the outcome ot the 
experiments with our previous results Tumors were treated with 800 HESW focused 
centrally on the tumor (treatment) Sham treatment was achieved by placing the tumor 
in such a way that the focus (as determined by pressure measurements) did not 
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encounter the tumor. Just before HESW (sham-)exposure, mice were anaesthetized 
with ketamine hydrochloride (Ketalar, Parke-Davis) 100 mg/kg for a 15 minute 
period. 
NMR Spectroscopy 
In vivo NMR spectroscopy was performed on a 4.7 tesla Bruker WM-200 
spectrometer as described previously.1" The mice were anaesthetized by means of a 
gas flow of 1.5% enflurane in a 0 2/N 20 mixture applied through a nosecone. Body 
temperature was monitored by a rectal probe and kept at 36-37°C by a flow of 
humidified warm air. The tumors were exposed through a matched hole in a Faraday 
shield and positioned partly inside the radio-frequency (RF) coil to prevent any 
contribution of signals from surrounding tissue. The magnetic field homogeneity was 
optimized by using the Ή NMR signal from tumor H20. Typical linewidths of this 
signal were 0 1 - 0.2 ppm. The animals were spectroscopically examined before and 4 
to 6 times after administration of HESW. 
2HNMR. 
The deuterium measurements were performed at a resonance frequency of 31 MHz, 
employing a home-built probe with a IH / 2H double tunable three-turn solenoidal coil 
with an inner diameter of 13 mm. After optimizing the field homogeneity the RF 
probe was removed from the magnet and the tumors were injected outside the magnet 
with 10-20 μΐ isotonic saline 2HO'0 solution at a single site (tumor centre) or at three 
sites (concentric) using a micro-syringe. During this procedure the tumors remained in 
their original position in the RF coil. The probe was repositioned in the magnet and 
serial 2H NMR measurements were started 90 seconds after injection. 
Deuterium spectra were collected in 45 second time blocks with 64 scans/block using 
a 10 ßs RF pulse, 2K data points and a spectral width of 5000 Hz. 
'H/^P NMR. 
Lactate detection by Ή NMR and pH measurement by 1 1P NMR were performed at 
200 and 80 MHz respectively, employing a home-built Ή / ^P double tunable two-
turn surface coil with an inner diameter of 10 mm. 
The Ή methyl signal of lactic acid has to be resolved from the co-resonating methyl 
signals of triglycerides irom subcutaneous adipose tissue. For spectral editing of the 
methyl signal of lactate the spin-echo difference spectroscopy method was used/'1 The 
spin-echo RF pulse sequence was preceded by a CHESS sequence to reduce the H 2 0 
signal54 and RF pre-pulses to reduce high flux signals." MK The prepulses and excitation 
pulse were all hard pulses.': Further H20 suppression was provided by the use of a 1-
1 refocussing pulse. Selective inversion of the methine (a) protons for lactate editing 
was achieved with a rotating-phase DANTE.10 In this way, on and off resonance 
inversion is realized by clock- and counter-clockwise phase rotation. During the 
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experiment the RF carrier frequency was set at 3.75 ppm upfield from the water 
signal. The spin-echo time was 152 msec and the scan repetition time was 2.5 
seconds. This way of lactate editing was found to be highly effective in the selection 
of the CH-, signal of lactate from the dominating methylene proton signals of 
triglycerides. In all cases the reliability of the sequence to detect the lactate methyl 
protons was tested by shifting the DANTE excitation band away from the 4.1 ppm 
position of the a lactate proton. 
In order to estimate the absolute concentration of lactate, a Ή NMR spectrum without 
H 20 suppression was also recorded with the same spin-echo sequence to obtain the 
tissue H 20 resonance. To avoid interference of H20 spin relaxation with the 
quantification of lactate a short echotime (1 msec) and a long scan repetition time (7 
seconds) were chosen. 
Measurements of the T2 relaxation time of tumor water proton spins were performed 
with a CPMG pulse sequence. The time delay time between the 180° pulses was set to 
2 ms. Data was acquired for 8 echo times between 8 and 320 ms. 
^P NMR spectra were obtained as previously described'" with a composite 90° pulse 
with a nominal 90° pulse at about 1 mm from the coil centre. The pulse repetition 
time was 3.5 seconds and the spectral width was 5000 Hz acquired with 4K data 
points. Typically 256 or 512 scans were acquired. 
DATA ANALYSIS 
Most NMR data was analyzed on an Aspect 3000 computer using standard Bruker 
software. For ^P NMR convolution difference was applied to remove broad spectral 
components using a line broadening of 300 Hz. In order to improve the signal-to-noise 
ratio, an exponential multiplication was used resulting in a linebroadening between 20 
and 30 Hz 
For 'H NMR an exponential multiplication was applied resulting in a linebroadening 
between 1 and 2 Hz. Water T2 relaxation times were obtained by fitting the integrals 
of the H 2 0 signals, obtained by the CPMG sequence, to a monoexponential decay 
function. 
Of the data obtained in the deuterium wash-out experiments, every first and each 
following fifth deuterium spectrum recorded, were evaluated employing the NMR1 
package (New Methods Research, INC, Last Syracuse, NY, USA) on a Sun Sparc 
station 330 (Sun Microsystems, INC, Mountain View, USA). FIDs were Fourier 
transformed and the phase was manually corrected. Deuterium resonances were semi-
automatically fitted to Lorentzian lineshape model functions. Integrals of the 
deuterium resonance were calculated and plotted as a function of time. 
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DOH wash-out and TBF 
Tumor blood flow was determined using compartment kinetic models taking tracer 
recirculation into account as described by Kim and Ackerman 76 7? In all cases the 
tumor deuterium residue wash-out could accurately be described by 
Q(t) = a e °" + b e "' (and a > ß > 0) 
This equation describes a flow model which represents (non-communicating) tasi and 
slow flow compartments in the tumor, where Q(t) is the quantified deuterium residue 
at time t, and the half-life times of the tracer in the fast and slow flow compartment 
are Tf = ln2/„ and Ts = '"2/„ respectively 
The (volume) fractions of the fast and slow components can be expressed as */
л
 ,, and 
b/ 
' л li 
The initial half life (t = 0) is defined by ',l2/7 where τ is the weighed average (·"* ы а + ь) 
of a and ß 
The formula TBF = 100 χ lambda χ r is then an estimate of the initial tumor blood 
flow (in units of ""/l(10txmm) Here lambda is the tumor-to-blood partition coefficient 
(ratio of the water weight of a unit mass of tumor to the water weight of a volume of 
blood) which was determined by measuring wet and dry weights of tumor and blood 
Dry weights were achieved by drying in an oven at a temperature of 90°C Lambda 
was calculated to be 0 906 ± 0 019 (in units of ml/t (n=5) Per animal, the half lifes 
were calculated using (nonlinear) least squares regression 
Tumor lactate quantification 
In order to estimate the absolute lactate concentration in the tumor, the resonance 
intensity of the lactate signal was related to the intensity of the water resonance 
The lactate concentration, expressed per tumor volume, was calculated by the 
following formula [lactate] = IF χ e '^ 2 l a a χ FL χ 2/, χ {RV,/RVW} χ [H20] 
T 2 h u is the spin-spin relaxation time of the methyl proton spins of lactate, tL is the 
echo time The lactate signal is recorded with a spin echo sequence having a tL of 152 
msec and hence T2 weighted Corrections can be made if the T2 value is known 
Adequate T2 relaxation time measurements of the methyl signal of lactate in 
subcutaneous tumors requires suppression of J modulation in conjunction with editing 
from triglyceride signals Presently we have not yet implemented this addition and 
have adopted a T2 value of 150 msec which is close to T2 values as determined for the 
methyl signal of lactate in the ral brain at 4 7 Τ m 
The inversion factor (IF) was set at 0 8 In control experiments with lactate solutions 
we observed that complete inversion of the methyl resonance of lactate by the 
application of the DANTE sequence could not be achieved About 80% of the original 
lactate signal intensity was recovered after editing This result is similar to 
experiments of Hanstock et al "' who also used a DANTE sequence tor inversion with 
a surface coil 
FL is the excitation profile correction due to the 1-1 pulse which is necessary because 
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the RF carrier was not exactly at the resonance position ot the methyl protons of 
lactate The factor Λ corrects for the fact that water has 2 protons and the lactate 
methyl group 3 RV, and RVW are the resonance integral values ot the methyl group of 
lactate and water respectively [H,0| is the concentration ot water per tumor volume 
Tumor lactate was also measured employing Ή NMR, after perchloric acid extraction 
(PCA) of freeze clamped tumor xenografts ' ' Before extraction tumors were weighted 
and a calibration standard (2 niM 3 (Tnmethylsilyl) propionic acid-d4 sodium salt) 
was added to the extract solution 
Phosphate energy metabolism and pH. 
The assignments ot the resonances and the calculation of the tissue pH from the 
inorganic phosphate (Pi) signal chemical shift in the λ 1Ρ NMR spectra were performed 
as described before ' " 
Statistics 
Due to the nonnormahty of the statistical distribution, Wilcoxon s test was used to 
compare the DOH wash out parameters in both groups For the same reason the 
lactate concentration and pH data were analyzed using the Koziol test 
Statistical significance was set at ρ < 0 05 
RESULTS 
Effects of HESW on TBF 
To determine the reproducibility ot the DOH wash-out method after intra tumoral 
injection of the tracer, D 20 was injected into the tumor at subsequent time intervals (3 
hours) We observed no dillerence in DOH wash out curves (data not shown) The 
DOH profiles were best fitted using the expression describing two components in the 
wash-out In this model a fast flow and slow flow component are characterized by 
their half life times (expressed as Tf and Ts of the tracer) and their (volume) fraction 
In each individual tumor a similar wash out was found either using single or multiple 
site injeaions In the following experiments DOH was injected at three sites in the 
tumor 
Figure 1 shows representative data ot two individual tumors, obtained before and after 
treatment with 800 HESW focused adjacent to the tumor (sham) or central on the 
tumor (treated) No significant differences in DOH decay before and after sham 
treatment were detected (figure la) In contrast, after the application of 800 HESW at 
the centre ot the tumor, a significant decrease in wash out was observed during the 
first 24 hours after treatment After 48 hours the wash-out curves showed pretreatment 
values (figure lb) 
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rel. HOD Intensity 
45 
100 
rel HOD Intensity 
Figure 1. Representative figures of relative HOD intensity in time detected by 2H NMR 
spectroscopy after intra-tumoral injection of an isotonic D,0 solution before (1), as well as at two 
(2). twenty-four (3), and forty-eight (4) hours after HESW exposure adjacent to the tumor (fig 
la, sham-treatment) or central on the tumor (fig lb, treated) 
59 
Figure 2 shows the mean calculated tumor blood flow (ml/100g.min) before and after 
exposure (n = 5 for each group) The mean pretreatment TBF value of the sham and of 
the treated group were slightly different but this was not significant (Wilcoxon; 
p = 0 89). 
Treatment with 800 HESW adjacent to the tumor resulted in an increase in mean TBF. 
However, these changes were not significant. After shock wave exposure to the centre 
of the tumor, the mean TBF decreased with approximately 75% after 2 hours and 
afterwards increased to 50% after 24 hours as compared to the mean pretreatment 
TBF As a result, TBF levels in the treatment group were significant lower than in the 
control group (Wilcoxon; ρ < 0.005 and ρ < 0.05 respectively). 
Tumor Blood Flow ml/[100gminl 
iL 
control 2 hours 24 hours 4Θ hours 
Figure 2. NU-1 kidney cancer xenograft tumor blood flow (in units of ,п|/|
Ш|1Хт1П) before (control) 
and after treatment with 800 HESW (white bars· sham-treated group, black bars· treated group) 
D,0 was injected at three bites intra-tumoral and TBF was calculated from the fitted bi-exponential 
wash-out curves Values are mean ± standard error of the mean (each group η = 5) 
In order to detect a possible differential impact on the fast and slow component of the 
DOH wash-out we evaluated the bi-exponential wash-out in more detail. In Table 2 
the half life times ot the tracer in the fast and slow compartment (Tf respectively Ts) 
as well as the volume fraction of the fast component before and two hours after 
treatment are presented. Two hours after exposure to 800 HESW a significant higher 
Ts and smaller volume fraction of the fast flow component (Wilcoxon; p = 0.01 and 
0.02 respectively) were seen. The remaining fast fraction showed no significant 
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différentes in Tt Similar analysis of these parameters for the subsequent period (10 
hours or more) revealed no clear patterns 
Table 1: Median half life times of the tracer (DOH) in the fast and slow compartment (Tf resp 
Ts) as well as the volume fraction of the tast component before and two hours after treatment 
Sham 
Treated 
Tf 
(n = 5)4 1 
(n = 5) 3 4 
PRE-TREATMENT 
Ts 
45 
33 
fraction 
86 
74 
Tf 
3 9 
2 7 
+ 2 
Ts 
21 
52 
HRS 
fraction 
80 
09 
The observations on TBF are in agreement with histology that has shown vascular 
disruption, stasis within capillaries and thrombosis immediately after HESW 
exposure ' " As these processes might affect relaxation times of water proton spins we 
studied T2 relaxations times of water proton spins in the rumor in the hours after 
HESW (see table 2 ) A significant decrease is observed tor this relaxation time thus 
providing an additional marker tor early HESW effects 
Table 2: Average T, relaxation limes values in seconds (mean + SD) of H>0 protons for three 
different NU-1 xenografts before and after exposure to 800 HESW 
T-, value 
before 
HESW 
0 63 ± 0 03 
2 hrs after 
HESW 
0 59 ± 0 06 
5 hrs after 
HESW 
0 48 ± 0 09 
ρ < 005 
Effects of HESW on tumor lactate levels and pH 
In figure 3 we show the effectiveness of lactate editing by the implemented spin-echo 
difference method By using selective inversion by the DANTE pulse train placed at 
4 1 ppm and at -2 1 ppm, the lactate signal is obtained at 1 3 ppm in the difference 
spectrum No lactate signal is obtained after shifting the selective inversion to 3 8 
ppm, thus confirming that the signal at 1 3 ppm originates from lactate 
Tumor lactate concentrations were estimated as described in materials and methods 
From 8 independent measurements an average lactate concentration of 7 1 + 19 raM 
was obtained for the renal tumor xenografts (pH > 7 0 measured by 1 ! P NMR, results 
not shown) This value is of ihe same order as the lactate concentration measured in 
other subcutaneous tumor models l "• % Fot two in vitro NMR measurements of PCA 
extracts of the renal tumor xenografts we estimated the lactate concentration to be 5 4 
and 7 8 mM These observations indicate that our in vivo determinations of lactate 
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concentration provides a good approximation for the actual lactate concentration 
despite the necessary assumption made for the T\ relaxation time of lactate methyl 
proton spins in the tumor 
NU I
 N u 1 
LAtTATT TDITING i CONTROI 
3 A B 
в SF ІЧТІ Е 
IvVERStO* 
I 
ι 
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Figure 3. Editing in in vivo Ή MR spectroscopy of NU 1 human renal cancer xenografts to 
resolve the methyl group resonance of lactate from resonances of triglycerides 
Left Lactate editing experiment Selective inversion by the DANTE pulses placed at 4 1 ppm 
(B) to invert the methine spins of lactate and at -2 1 ppm (A) for off resonance inversion 
The lactate signal is obtained at 1 3 ppm in the difference spectrum (A-B) 
Right Control experiment No signal is observed at 1 3 ppm in the difference spectrum (A-B) 
after shifting the selective inversion to 3 8 ppm thus confirming thai the signal at 1 3 ppm 
obtained in the previous experiment originates from lactate 
The effect of HESW treatment on lactate levels and tumor pH was determined 
simultaneously by combining M P and Ή NMR (see fig 4A) There was no statistical 
significant difference tor pH and lactate pretreatment levels between the sham treated 
and HESW treated group 
HESW treatment resulted in a maximal increase in the average estimated lactate 
concentration from 8 8 mM (range 5 9 to 11 5) to 16 5 mM (range 14 9-17 9) 4 hours 
post treatment The lactate concentration decreased to pretreatment levels within the 
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following 48 hours In principle an increase of the lactate signal may be due to an 
increase in T2 relaxation times ot the methyl proton spins after HESW application but 
it would require substantial changes in T2 to explain the intensity increases observed 
Note that the T2 relaxation time ot water proton spins does not increase after HESW 
exposure (see Table 2) 
mM lactate pH 
0 5 10 15 20 25 
hours 
Figure 4A. Changes in láclate levels and pH, in the NU 1 kidney cancer xenograft after treatment 
with 800 HESW, focused on the centre of the tumor Values are mean + standard error of the 
mean, (n = 5) The dashed vertical bars represent the range of values after the sham-treatment 
procedure (n = 5) 
The changes in pH showed a similar, but inverse, temporal pattern as the increase in 
the estimated lactate concentration After 4 hours the mean pH was decreased from 
7 06 (range 7 12 to 6 97) to 6 52 (range 6 45 to 6 60) Thereafter the pH increased to 
pretreatment values in a similar time span as the lactate concentration The Koziol test 
revealed a significant difference in the temporal pattern between treatment and sham-
treatment for the lactate concentration as well as the pH (both ρ < 0 001). A plot of 
pH as a function of the estimated lactate concentration (Fig 4B) reveals a linear 
relationship between these two variables This suggests that pH changes are caused by 
variations in lactic acid content although HESW may generate protons from other 
sources, e g hydrolysis of nucleoside triphosphates, which may also contribute to pH 
changes Indeed the HESW induced temporary metabolic decline, as represented by 
the NTP/p, ratio, shows a similar time dependent pattern as lactate ( data not shown, but 
see ref 155) 
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PH 
L a c t a t e 
Figure 4B Plot of pH values and estimated lattale concentrations [mM| showing the linear 
relationship between these variables 
The correlation coefficient for the linear correlation between lactate and pH is -0 9 
DISCUSSION 
Although HESW have been successfully used as an anti-tumor treatment modality in 
different animal tumor models, the mode ot action of HESW is still largely unknown 
Recently, in vivo MP NMR spectroscopy in the NU-1 kidney xenograft showed drastic 
alterations in tumor cell metabolism, and a temporary tumor growth inhibition after 
HESW exposure ' " Since HESW, generated extra-corporally, can be precisely focused 
on a limited area in the body, these findings revealed a new potential application for 
this form of acoustic energy At present it is unclear whether the metabolic changes 
observed are a direct or an indirect effect of the shock waves The metabolic changes 
seem to be related to the induction of a temporary ischemia, due to an impaired tumor 
blood flow and perfusion 
In the present study it is demonstrated that HESW causes a reduction in D20 efflux 
from the tumor, a decrease in the T2 relaxation time ot tumor water proton spins and 
an increase in estimated lactate levels concomitant with a decrease in pH of the tumor 
tissue 
D20 efflux measurements by 2H NMR can be used to evaluate TBF and perfusion in 
response to therapeutic interventions 4268 "R 
In our experiments, a bi-exponential tracer residue decay was observed after applying 
DOH intra-tumoral in non-treated NU-1 tumors The tracer wash-out was best 
described by a mathematical model using a fast and slow flow component of DOH 
decay within the tumor This wash-out pattern was not influenced significantly by the 
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number of D О injection sites Repeating the experiment after 5 hours also revealed 
similar DOH wash-ouls Our results are in agreement with similar experiments in the 
RIF 1 tumor77 and the bi exponential clearance kinetics are likely due to TBF 
heterogeneity *' 
The studies presented here show a pronounced effect of HESW on the TBF in the 
NU-1 human kidney cancer xenograft When the HESW were focused on the tumors, 
a mean reduction in TBF of 75% of the initial TBF two hours after HESW treatment 
was observed Exposure to 800 HESW focused adjacently to the tumor did not 
influence TBF significantly The reduction in TBF was temporary and the DOH wash­
out increased to non treated profiles These results demonstrate that a reduction in 
TBF by HESW is only effectuated if the tumor (or at least a major part) is subjected 
to the high pressure focal area 
In this study the major effect was seen in the fast How component suggesting that the 
most viable pari of the tumor with the highest TBF is most sensitive towards the shock 
waves 
How can these effects of HESW on TBF be explained' Recent studies indicate that 
cavitation, presumably associated with the tensile pressure, have a damaging effect at 
the vascular level 18 P 7 In addition microscopic studies in the NU 1 xenograft as well 
as in several other animal tumor models have shown vascular (capillar) disruption 
extravasation of erythrocytes and the formation of thrombosis and necrosis when the 
tumors were placed in the focal beam with high pressures 1 4 " 7 P n P I Thus, the impact 
of HESW on functional vascularization (TBF) most likely results from the generation 
of cavitation which subsequently act on the tumor vascular component (damaging and 
or activation of endothelial cells) Whether more gas holding nuclei are present and 
thus cavitation are induced to a greater extent in the well perfused (fast compartment) 
parts of the tumor is speculative The Ή NMR spectroscopy studies showed a 
temporary increase in lactate concentrations From this observation one can conclude 
that the reduction in TBF results in cellular hypoxia and that consequently anaerobic 
glycolysis becomes the main cellular energy source Since the TBF is reduced the 
increased lactate concentration could also be explained by a disturbed outflow of 
lactate However the concomitant monitoring of ΉΡ NMR revealed a synchronous 
temporary change in tissue pH (ι e , intra cellular tumor pH), suggesting that an 
enhanced lactic acid synthesis is important in tissue acidification 6S Ч6 The outcome of 
the ^P/'H NMR studies supports the hypothesis that the HESW induced tumor growth 
suppression is mediated by an impact on the functionality of the vascular component 
of the tumor 
Quantitative measurement of TBF and perfusion may not only contribute to the 
knowledge of HESW induced changes in vascular functionality, moreover this may 
provide the rational tor the use of HESW in a combined treatment setting, ι e , 
combining HESW with chemo- or immunotherapy 
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Until now, as a result ol the lack of knowledge on the mode of action, treatment 
schedules have been determined empirically The findings here presented can provide 
a better rational tor developing more effective combined treatment modalities, e g , 
the use of HESW adjuvant to systemic drugs that have an increased effect in an acid 
environment, or that block glycolysis In addition to a diminished drug outflow, a 
decreased TBF and perlusion may also enhance diffusion processes and thus result in 
an enhanced drug penetration in the tumor 
The extent of modulation of local TBF and perfusion provoked by HESW treatment, 
with subsequent changes in metabolism, will be of importance in designing adjuvant 
(local or systemic) anti cancer therapies 

Chapter 6 
THE EFFECTS OF SUCCESSIVE HIGH ENERGY 
SHOCK WAVE TUMOR ADMINISTRATION ON 
TUMOR BLOOD FLOW 
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INTRODUCTION 
Experimental animal studies using different tumor model svstems, have shown that 
temporal growth suppressive effens can be achieved by treating tumors with high 
energy shock waves (HESW) " 1 7 ' 7 p ' m '71 Moreover combination of HESW with 
chemotherapy or cytokines ïesulted in additive or synergistic antitumor 
ellects M l " l2" P 1 A number of variables that influence these antitumor cllects have 
been identified including tumor vascularization, time interval between successive 
tieatments number of HESW, number ol HESW loci tumor size and tumor model 
system b 7 , , i m 
Several studies have been perlormed to clanly the mode of action of HESW Gamarra 
et al demonstrated with the use of autoradiography ol iodo [UCJ antipyrme a 
temporary reduction of the perfusion of A mel-λ tumors after treatment with HESW S1 
Using magnetic resonance spectroscopy (MRS) techniques we found a temporary 
impairment of tumor blood flow (TBF) in the NU-1 renal cancer xenograft after 
HESW application, resulting in a metabolic mactivation and acidification ol the 
t u m o r ' " " 7 Histological studies ol this NU-1 tumor show changes in tumor 
vasculature due to HESW exposure ι e disrupted capillaries, extravasation of 
erythrocytes distended microvessels with tightly packed erythrocytes and thrombi 
formation r " Apparently, one of the main targets of HESW is the vascular 
system , 4 , , f t 7 P I № 1 " 1 " 
As mentioned above, earlier studies using different tumor models revealed thai the 
antitumor effects ol HESW could be enhanced by repeated HESW tumor treatments 
and that shoitening of the interval between subsequent HESW treatments lrom 24 
hours to S hours leads to more effective tumor growth inhibition i : ' '7' It is templing to 
speculate that increased elficacy is associated with the extent and duration of the 
decrease of TBF after successive HESW exposures 
We therelore e\aluated the eltects of repeated HESW application on TBF As in our 
previous MRS study, intra-tumoral in]ected deuterated water (D,0) was used as a 
MRS detectable tracer for measurement of TBF и This technique has proved to be a 
sensitive and reproducible method in the determination of TBF and perfusion u 7" *" U№ 
Moieovei since the MRS TBF measuiement method is non destructive and relatively 
non invasive, it is possible to measure TBF in the same subject repeatedly It is 
therelore an ideal technique to monitor changes in tumor blood flow after repealed 
HESW tumor administrations 
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MATERIALS and METHODS 
Animals 
Xenografts weie transplanted in six to eight week old male BALB/c athymic mice 
(Boinholtgârt, Ry Denmatk) The mite weie kept m groups or five in PAG type 2 
cages coveied with an iso cap (Ша Credo, France) lor sterile conditions The mice 
weie led ad libitum with irradiated SRM-A MM food (Hope Farms, Woerden, The 
Netheilands) and dunking water was acidified (pH 3) 
1 umors 
The human renal cell carcinoma NU-1 xenograft was established in our laboratory by 
subcutaneous implantation of small tumor pieces derived from a tumor nephrectomy 
specimen 1u Foi the HESW studies tumors were implanted subcutaneously as trocar 
pieces at the uppei part of the hind limb Passages 9-14 in vivo were used The three 
dimensions of the lumoi were determined with a precision sliding calliper by 
measuring the maximum diameter and the diameters perpendicular to it The tumor 
volume was calculated by the equation (LxWxH) χ (π/6) Tumors were allowed to 
grow to a volume of 300-350 mm (mean 325 mm1) 
HESW 
HESW were geneiated by an experimental set up of the commercially available 
electromagnetic shock wave source Lithostar Plus (Siemens AG, Erlangen, Germany) 
The physical and technical characteristics of this experimental shock wave source have 
been described recently 1M In short the main lrequency of the pulse was 200 kHz 
(ïesonance frequency of the system) The focal area (defined as pressure 6 dB zone) 
was 4 χ 40 mm (lateral χ vertical) at maximum setting 
Just before HESW (sham (exposure mice were anaesthetized with ketamine 
hydrochloride (Kelalai, Parke Davis) 100 mg/kg for a 15 minute period Mice were 
kept in fixed position in a plastic tube which was placed in the water bath The tumor 
bearing leg was projected through a hole in the basis of the plastic tube and the centre 
of the tumor was positioned in ihe focal area through a three dimensial positioning 
system Sham exposuie was achieved by placing the tumor in such a way that the 
focus (as determined by pressure measurements) did not encounter the tumor Each 
HESW administration consisted ol in total 800 pulses with an energy density of 0 47 
mJ/тпГ (pulse repetition frequency of 2 Hz) All experiments were carried out with 
degassed water at 37°C The NU 1 tumors were exposed twice to HESW (at Τ = 0 
and Τ = 24 hours) 
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NMR Spectroscopy 
In vivo NMR spectroscopy was performed on a 4 7 tesla Bruker WM-200 
spectrometer as described previously 15<i The mice were anaesthetized by means ot a 
gas now ot 1 5% enflurane in a 0 2/N 20 mixture applied through a nosecone Body 
temperature was monitored using a non-magnetic temperature probe and maintained at 
37° С by a How of humidified warm air The tumors were exposed through a matched 
hole in a Faraday shield and positioned partly inside the radio-frequency (RF) coil to 
prevent any contribution of signals trom surrounding tissue The magnetic field 
homogeneity was optimized by using the Ή NMR signal from tumor H20 Typical 
linewidths ot this signal were 0 1 - 0 2 ppm The animals were spectroscopically 
examined two hours betöre the first administration ot HESW (T = -2) and at Τ = 2, 
T = 8, T=16, T = 26, T = 32 and T=40 hours 
The deuterium measurements were performed at a resonance frequency of 31 MHz, 
employing a home-built probe with a IH / 2H / 31P triple tunable three-turn 
solenoidal coil with an inner diameter of 14 mm After optimizing the field 
homogeneity the RF probe was removed from the magnet According to the results of 
Larcombe-Mc Douall and Evelhoch 60-70 μΐ PBS-D20 was injected (concentric) 
intratumoral at three different sites, using a 30 gauss micro-syringe "" During this 
procedure the tumors remained in their original position in the RF coil The probe was 
repositioned in the magnet and serial 2H NMR measurements were started within 70 
seconds after injection 
Sixty-tour deuterium spectra were collected in 49 second time blocks with 64 
scans / block using a 10 μΝ RF pulse, 2K data points and a spectral width of 5000 Hz 
Data Analysis 
For each timepoint, every first and following fifth deuterium spectrum recorded, were 
evaluated employing the NMR1 package (New Methods Research, INC, Last 
Syracuse, NY, USA) on a Sun Sparc station 330 (Sun Microsystems, INC, Mountain 
View, USA) Free induction decays (FIDs) were Fourier transformed and the phase 
was manually corrected Deuterium resonances were semi-automatically fitted to 
Lorentzian hneshape model functions Absolute integrals of the deuterium resonance 
were calculated and plotted as a function of time The D20 clearance curves thus 
obtained are presumed to represent blood flow within the whole tumor 83 
Clearance curves of D 20 were best fitted using a single compartment model Tumor 
blood flow was thus determined using a single compartment model as described by 
Kim and Ackerman 7Я In all cases the deuterium residue wash-out could accurately be 
described by 
Q(0 = Qbu + [Q(0) - QbJ * exp(-kt) 
This equation describes the simplest first order kinetic "single compartment model" 
where Q(f) is the tracer quantity at time t, QhE is the non zero steady-state tracer 
71 
background, Q(0) is that at t = 0 and к is the first order rate constant governing 
tracer wash out.7* 
Since the steady-state tracer background (residual from previous experiment) already 
have been subtracted from the original decay curve the deuterium wash out decay can 
be formulated as: 
Q(t) = Q(0) χ exp(-kt) 
The formula TBF = 100 χ lambda χ к is then an estimate of the initial tumor blood 
flow (in units of m ' / l l K l g x m m ) . Here lambda is the tumor-to-blood partition coefficient 
(ratio ot the water weight ot a unit mass of tumor to the water weight of a volume of 
blood) which was determined by mea-suring wet and dry weights of tumor and blood. 
Dry weights were achieved by drying in an oven at a temperature of 90CC. Lambda 
was calculated to be 0.906 ± 0.019 (in units of m7g (n = 5). 
Statistics 
Because of the normal distribution pattern of the calculated TBF, two-sided Τ test was 
used to compare the TBF between the control and HESW applicated group and to 
evaluate the effect of the second HESW administration. Statistical significance was set 
at ρ < 0.05. 
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Figure 1. D
:
0 outflow curves, wit data points each 5 measurements, at 7 different time points of 
a ham treated control lumor obtained by 2H MRS after intra-tumoral injeclion of an isotonic D,0 
solution 
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RESULTS 
According to the results of Larcombe-Mc Douall and Evelhoch 60-70 μ\ D 20 was 
injected intratumoral at three different sites, presuming that the D
:
0 clearance curves 
thus obtained represent blood flow within the whole tumor.81 The D
:
0 clearance 
curves were best fitted using an one compartment model. 
Tumor blood flow in control tumors 
In Figure 1 seven D 2 0 outflow curves obtained at T= -2, T = 2, T = 8, T=16, T = 26, 
T = 32 and T=40 hours from one representative control NU-1 tumor are shown. 
Calculated mean TBF of all HESW non-exposed control tumors (N = 5) for the 
subsequent time points revealed no significant changes in TBF during this time period 
(p = 0.17, fig.2). 
Π . - L 
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HESW 
Figure 2. Calculated mean tumor blood flow (in units of ml/l00gxmin) with SD of 5 sham treated 
control tumors (gray bars) and of five HESW treated tumors (black bars). Tumors were HESW or 
sham treated at Τ = 0 and at Τ = 24 hours. 
Tumor blood flow in HESW exposed tumors 
The mean pre (sham) HESW exposure TBF values in the HESW and control group 
were statistically not different (fig. 2). Administration of 800 HESW on the centre of 
the tumor resulted in a decrease of the mean TBF of 46 + 19 % after 2 hours and 16 
± 30% after 16 hours. A second HESW exposure, 24 hours after the first, resulted in 
a decrease of the mean TBF with 37 + 23 % after 2 hours and 16 ± 34% after 16 
hours when compared to pre-exposure values. As a result, TBF levels two hours after 
the first and second HESW administration were significantly lower than the pre-
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exposure TBF (p = 0 02 and p=0 04 respectively) Moreover, comparing the effect on 
TBF of the first and second HESW administration revealed no significant difference 
(p=0 45) 
DISCUSSION 
Recently it has been demonstrated that the vascular functionality ot tumors is the 
primary target ot HESW tumor therapy " ' " Exposure ot tumors with HESW causes a 
temporary decrease in TBF resulting in a metabolic inactivation and 
acidification ' " ' " The modulatory effects ot HESW on TBF may be used to overcome 
the limited efficacy ot other treatment modalities For instance, a threefold increase of 
the intra tumor concentration ot systemically given tumor necrosis factor alpha (TNF-
a) was achieved after HESW tumor treatment2" Moreover, the HESW induced 
decrease ot TBF may probably improve the efficacy of thermotherapy Monitoring the 
effects on TBF ot (repeated) HESW exposure(s) is therefore of importance in order to 
improve the efficacy of HESW treatments, not only as monotherapy but also in 
combination with other therapies A 24 hours time interval was chosen because we 
wanted to investigated the effects of a second HESW treatment after functional 
recovery of the TBF 
Several methods can be used to measure blood flow and tissue perfusion, either 
directly or indirectly ч Among the methods developed to measure TBF indirectly, 
radiolabeled and MRS detectable tracers are most commonly used There are several 
advantages ot MRS based methods above the use of radiolabeled tracers A4 First ot all 
MRS is nondestructive and relatively non-invasive Secondly, stable isotopes (e g 
deuterium or fluorine) are used, eliminating problems of radiation exposure and 
special tracer handling Finally, concurrent Ή and 1 ! P MRS measurements can be 
performed, evaluating tissue metabolism On the other hand, the main disadvantage of 
this technique is that it requires specialized and expensive equipment In the present 
study we used the deuterium clearance method to calculate TBF at various time points 
after successive HESW exposures In an earlier study we already demonstrated that in 
the NU 1 tumor this method gives reproducible deuterium outflow curves after 
repeated intra-tumoral D,0 injections, independent of the number of injection sites ' " 
Here we demonstrate that a second HESW application of this NU-1 tumor result in a 
decrease in tumor blood flow which is statistically not different from the effect on 
TBF seen after the first HESW exposure Both HESW exposures resulted in a 
significant decrease of TBF 2 hours after therapy, followed by normalization to 
pretreatment values within 16 hours The extent and duration of the decrease in TBF 
after the first HESW administration were comparable with those described earlier ' " 
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However the absolute TBF flow values ot the NU-1 tumors used in this study were 
much lower than found earlier ' " Several reasons can be taken into consideration tor 
this major discrepancy First, there are major differences in tumor doubling time 
between the early passages used now and the late passages used earlier (8 and 3 5 
days respectively) The lower tumor doubling time of these early passages of the NU-
1 tumor might well be representative for a less well developed vascular system 
Secondly, since the MRS surface coil used in the present study was bigger than in our 
used earlier, the tumors needed to grow to significant higher volumes compared to the 
aforementioned study For other xenografts it has been demonstrated that TBF values 
correlate with tumor-volume, the bigger the tumor the lower the TBF "4 Finally, in 
contrast to our earlier study, D20 clearance curves were best fitted using a one 
compartment model For the RIF tumor it has been demonstrated that TBF values, 
calculated using a mono-compartment model were significant lower compared ro the 
TBF values calculated from the same clearance curves, using a two compartment 
model 77 
Earlier studies, using different tumor models, revealed that the antitumor effects ot 
HESW could be enhanced by repeated HESW tumor treatments and that shortening of 
the interval between subsequent HESW treatments leads to more effective tumor 
growth inhibition '2I '" Our present TBF study rationalizes the shortening of the time 
interval between HESW exposure towards 2 3 hours Reperfusion ot the HESW 
exposed tumor can not occur and the prolonged ischemia will induce more cell death 
Denekamp et al reported for the SA F mouse tumor that 15 hours ot ischemia was 
required to obtain local cure of the tumor Assuming that such a long time period will 
also be necessary for other tumors, this would imply that 5 6 successive HESW 
treatments should be given to achieve sufficient ischemia time to provoke complete 
local tumor regression v 
Optimahzation of time schedules time schedules for HESW treatment in combination 
with other therapies, e g systemically given drugs (chemotherapy or BRMs), based on 
this study, will be more difficult Recently we demonstrated that a threefold increase 
in the intra-tumor concentration of systemically given TNF-a can be achieved after 
one HESW tumor treatment2H Yet it is not known to what extent TBF must be 
recovered before a second treatment of HESW in combination with systemically given 
drugs would only be ettective It is obvious that drugs need to have access to the 
tumor belore the selective shut down of the tumor vasculature will result in increased 
intra tumoral drug levels 
In conclusion, it becomes clear that HESW are capable to damage selectively the 
tumor vasculature It is tempting to speculate that this HESW induced decrease of 
tumor blood flow will be able to rule out problems of inadequate drug uptake and non 
optimal distribution in the rumor The potency ot HESW to increase the efficacy of 
systemic therapies by selective temporary changes in TBF will possible determine its 
clinical application 
Chapter 7 
SUMMARY AND CONCLUSIONS 
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SUMMARY AND CONCLUSIONS 
The application of magnetic resonance based techniques has expanded in medical 
science in the past few years. In particular, magnetic resonance imaging (MRI) has 
become a routine examination in clinical medicine, but magnetic resonance 
spectroscopy (MRS) is still in its experimental setting although several studies have 
demonstrated that MRS can be used to monitor biochemical processes. Several 
applications for MRS like improvement of diagnosis by providing metabolic markers, 
monitoring the response to therapy by MRS detectable metabolites and monitoring the 
pharmacokinetics of cancer drugs are of particular clinical interest. This thesis 
describes experimental studies on the potential applications of MRS in urological 
oncology. In chapter 2, 3, and 4 in vitro MRS studies are described to determine the 
possible value for MRS in diagnosis and staging of prostate cancer. In chapter 5 and 6 
in vivo MRS was used to monitor the effects of HESW as anti-tumor therapy in order 
to elucidate its working mechanism and to provide a rational for improving the current 
treatment schedules of this new experimental anti-cancer therapy. 
Chapter 2 describes an in vitro Ή and 1 ]P MRS study of perchloric acid extracts of 
human prostate tissue obtained by transurethral resection. This included tissue of 
patients with benign prostatic hyperplasia (BPH), prostatic adenocarcinoma and non-
malignant tissue (i.e no sign of histological BPH or cancer). Prominent resonances in 
the MR spectra could be assigned and were quantified. The citrate / lactate, 
citrate / total choline, phosphocholine / total creatine, choline / total creatine, 
alanine / total creatine, phosphoethanolamine / total phosphate, phosphocholine / total 
phosphate and glycerophosphoethanolamine / total phosphate ratios were statistically 
different for the prostate cancer samples as compared to the BPH specimens. We 
therefore concluded, that MRS may be of additional use in the diagnosis of prostate 
cancer. 
In chapter 3 we investigated whether the differences in biological potential of rat 
prostate cancers correlated with changes in metabolic profiles. Ή and 1 IP MR spectra 
were acquired from perchloric acid extracts of seven Dunning R-3327 rat prostate 
tumor sublines. Several metabolic ratios, e.g. phosphocholine / total phosphate, 
choline / total creatine and inositol / total creatine did not correlated specifically with 
any of the tumor biological characteristics. However, in terms of these ratios we could 
discriminate between the well differentiated, non-metastatic and hormone dependent 
sublines versus the poorly differentiated or anaplastic, metastatic and hormone 
independent sublines. The glycerophosphoethanolamine / total phosphate, 
glycerophospho-chohne / total phosphate and phosphocreatine / total phosphate ratios 
correlated with differentiation grade and the difference in glycerophosphoryl-
glycerol / total phosphate ratio between metastatic and non-metastatic sublines was 
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highly significant No correlation between hormonal sensitivity and any ot the MRS 
detectable metabolites were tound Based on this study we concluded that for rat 
Dunning prostate tumors biological parameters correlated with metabolic profiles 
To extend these observations tor human prostate cancer, four well established human 
prostate cancer cell lines were studied with Ή MRS to compare differences in 
metabolic content with tumor biological behaviour In chapter 4 we demonstrate that, 
despite unique metabolic profiles, the relative creatine and citrate levels can be used to 
discriminate the androgen dependent LNCaP cell line from the androgen independent 
DU-145, TSU and PC-3 
Chapter 5 describes how in uvo MRS can be used to investigate the effects ot HESW 
exposure of NU-1 tumors on particularly tumor blood flow (TBF) Also changes in 
metabolism using multinuclear 'H/H/1 1? MRS were thus studied By monitoiing 
deuterium washout, we could demonstrate that a dramatic reduction in TBF is seen it 
the tumor is subjected to HESW In addition, the concomitant monitoring of Ή and 
MP MRS showed a transient acidification of the tumor and an increase in the lactate 
concentration All changes were temporary and recovered to pretreatment levels 
These studies support the hypothesis that the functional vascularity is an important 
target ot HESW exposure 
Since the anti-tumor effects ol HESW are probably associated with the extend and 
duration of the decrease of TBF after successive HESW exposures we evaluated in 
chapter 6 the effects ot repeated HESW tumor administration on TBF We 
demonstrated that a second HESW exposure, administrated after functional recovery 
of the tumor, resulted in a decrease in TBF which is not different from the effect on 
TBF seen after the first HESW exposure Both HESW exposures resulted in a 
significant decrease ot TBF 2 hours after therapy, followed by normalization to 
pretreatment values within 16 hours The extent and duration ot the decrease in TBF 
after the first HESW administration were comparable with those described in chapter 
*> These observations provide a rational to shorten the time interval between HESW 
mono-treatments to 2-3 hours 
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Samenvatting en conclusies 
Het gebruik van kernspinresonantie technieken in de medische wetenschap heeft in de 
afgelopen jaren een explosieve groei doorgemaakt In het bijzonder is de beeldvorming 
met kernspin resonantie, ook wel magnetische resonantie imaging (MRI) genoemd, 
een routine afbeeldingstechniek in de kliniek geworden De magnetische kernspin 
resonantie spectroscopie (MRS), met behulp waarvan stofwisselingsprocessen in 
weefsels bestudeerd kunnen worden, wordt voornamelijk voor research doeleinden 
gebruikt Verschillende toepassingsmogelijkheden voor MRS zoals a_ verbetering van 
diagnostiek met behulp van metabole markers b_ evaluatie van therapie ç_ 
farmacokinetiek studies van (kanker) medicamenten kunnen van waarde zijn voor de 
kliniek 
In dit proefschrift worden experimentele studies beschreven, om de waarde van MRS 
voor de urologische oncologie te bepalen In hoofdstuk 2, 3 en 4 worden in vitro MRS 
studies beschreven, waarin getracht wordt de waarde van MRS voor de diagnostiek 
van prostaataandoeningen, in hel bijzonder prostaatkanker, te bepalen In hoofdstuk 5 
en 6 worden in vivo MRS studies beschreven ter evaluatie van het 
werkingsmechanisme van HESW als anti-tumor therapie 
In hoofdstuk 1 wordt een algemene korte inleiding over de algemene principes en 
toepassingsmogelijkheden van in vitro en in vivo MRS voor de oncologische research 
gegeven 
Hoofdstuk 2 beschrijft een in vitro Ή en 1 ]Ρ MRS studie van perchloorzuur (PCA) 
extracten van transurethral resectie materiaal specifiek voor de normale prostaat, 
benigne prostaat hyperplasie (BPH) en adenocarcinoom van de prostaat De meest 
uitgesproken resonanties in de MR spectra werden geïdentificeerd en gekwantificeerd 
De volgende ratio's citraat/lactaat, citraat/totaal choline, tostocholine/totaal creatine, 
choline/totaal creatine, alanine/totaal creatine, fosfoethanolamine/totaal fosfaat, 
tosfocholine/totaal fosfaat en glycerofostoethanolamine/totaal fosfaat waren 
verschillend bij BPH in vergelijking met die bij het adenocarcinoom Op basis van 
deze resultaten zijn we tot de conclusie gekomen, dat MRS mogelijk van waarde kan 
zijn in de diagnostiek van prostaat kanker 
In hoofdstuk 3 hebben we met behulp van het Dunning prostaat tumor model 
onderzocht, of verschillen in tumor biologisch gedrag correleren met veranderingen in 
metabool profiel Een Ή en 3 'P MRS studie van PCA extracten van zeven 
verschillende subhjnen werd uitgevoerd Dezelfde metabolieten als in de humane 
spectra werden geïdentificeerd en gekwantificeerd Verschillende ratio's 
fosfocholine/totaal fosfaat, choline/totaal creatine en inositol/totaal creatine, konden 
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worden gebruikt om de agressieve sublijnen (slecht gedifferentieerd, metastaserend en 
hormonaal onafhankelijk) van de relatief benigne sublijnen te onderscheiden De 
glycerotosfoethanolamine/totaal tostaat, glycerofosfochohne/totaal fosfaat en 
fosfocreatine/totaal fosfaat ratio's waren significant verschillend in de goed en matig 
gedifferentieerde sublijnen in vergelijking met de slecht gedifferentieerde en 
anaplastische sublijnen De hoogte van de glycerofosforylglycerol/tolaal fosfaat ratio 
correleerde met uitzaaiend vermogen van de Dunning sublijnen In deze 
dierexperimentele studie kon geen correlatie gevonden worden tussen hormonale 
response en de gekwantificeerde metabolieten 
In hoofdstuk 4 hebben we onderzocht, of de correlatie tussen biologisch gedrag en 
metabool profiel, zoals die in hoofdstuk 3 gevonden werd, ook voor humane prostaat 
kanker geldt Hiertoe werden PCA extracten van vier humane cellijnen met 'H MRS 
onderzocht De resultaten van deze studie laten zien, dat de hormonaal afhankelijke 
LNCaP cellen relatief meer creatine bevatten dan de andere drie hormonale 
onafhankelijke cellijnen Tevens suggereren de resultaten, dat het citraat gehalte van 
LNCaP cellen hoger is dan dat van de DU 145, TSU PR1 en PC-3 
Op basis van de in hoofdstuk 3 en 4 beschreven studies concluderen we, dat het met 
behulp van MRS mogelijk is om prostaat tumoren met verschillend biologisch gedrag 
van elkaar te onderscheiden 
Om meer inzicht te verkrijgen in het werkingsmechanisme van hoog energetische 
schokgolven (HESG) als anti-tumor therapie werd in vivo MRS gebruikt Deze 
techniek verschaft informatie over metabole veranderingen in viabele tumorcellen, 
welke het doel zijn van de HESG behandeling 
In hoofdstuk 5 zijn de eltecten van een eenmalige HESG blootstelling op het 
tumorcelmetabohsme en de tumor bloed doorstroming (TBF) beschreven Een drama­
tische, maar lijdelijke, verlaging van de tumor doorbloeding werd gezien In hetzelfde 
tijdsinterval werd met behulp van Ή en ? 1P MRS een daling van de pH en een stijging 
van het melkzuur gehalte gezien Daar we, mede op basis van deze MRS studie, 
mogen stellen, dat de doorbloeding van de tumor waarschijnlijk het voornaamste 
aangrijpingspunt van HESG therapie is, is het in beeld brengen van de mate en de 
duur van de gestoorde TBF na herhaalde HESG blootstellingen belangrijk voor de 
ontwikkeling en verbetering van therapie protocollen Het doel van de in hoofdstuk 6 
beschreven studie was, om de effecten op de TBF na herhaalde HESG blootstelling te 
evalueren In dit hoofdstuk laten we zien, dat een tweede HESG blootstelling, 24 uur 
na de eerste, resulteert in een verlaging van de TBF, welke niet verschilt van het 
effect op de TBF na de eerste keer Twee uur na beide HESG blootstellingen wordt 
een significant verlaagde TBF gezien, welke binnen zestien uur herstelt naar normale 
waarden Op grond van deze resultaten concluderen we, dat het tijdsinterval tussen 
opeenvolgende HESG behandelingen verlaagd kan worden tot 2 a 3 uur 
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PERSPECTIVES 
MRS as diagnostic tool in prostate cancer 
Nuclear magnetic resonance based techniques provide new diagnostic tools for clinical 
use. The development of endorectal MRI surface coils improved the detection and 
staging of prostate cancer. Likewise, MRS of the prostate can be performed (figure 1: 
MRI/MRS of prostate of young volunteer). Since little is known about the biochemical 
content of the prostate, in vitro MRS studies were performed in order to gain insight 
in the metabolic content. Subsequently, the potential value of MRS in improving 
diagnosis of prostate malignancies can be determined. Moreover, using different 
prostate tumor models systems, differences in metabolic content of prostate tumors can 
be related to their different tumor biological potential. From chapter 2-4 we can 
conclude that there are several potential markers for prostate cancer, e.g., citrate and 
(phospho)choline. Moreover, our results suggest that prostate tumors with different 
biological potential can be identified using MRS. 
In vivo 'H MRS studies of the prostate with endorectal coils continue to support the 
importance of citrate as marker of malignancy in the prostate. In an ongoing in vivo 
MRS study of the prostate not only citrate but also choline appear to be useful in 
discriminating BPH from adenocarcinoma of the prostate.62 However, the results of 
these single volume localization studies may be ambiguous because of the known 
heterogeneity of prostate cancer. Spectroscopic imaging techniques may overcome 
these problems and may enable visualization of the spatial distribution of citrate, 
choline or other metabolites. If spectroscopic imaging of small volumes of less then 1 
cc becomes feasible, metabolic maps of the prostate will probably help to delineate the 
extension of the tumors and thus allow better local staging. Secondly, in the future 
prognostic information about the biological behaviour of the lesion may be derived 
from MRS. 
The question "Is there a clinical role for MRS in detection and staging of prostate 
cancer" remains to be solved. Although multi-center trials are clearly needed to solve 
that question, this thesis indicates that MRS will play a role in the diagnosis of 
prostate diseases, i.e. BPH and prostate cancer. 
MRS monitoring HESW anti-tumor therapy 
A number of years ago Oosterhof and Smits wrote "We do not know whether high 
energy shock waves will ever become clinically applicable in (urological) 
oncology.".'"I56 This thesis will not answer that particular question, but based on the 
MRS studies described in chapter 5 and 6 we further improved our knowledge about 
the mode of action of HESW in tumor therapy. We concluded that one of the main 
targets of HESW is the functional vascularity of the tumor. 
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Figure 1. MRI / MRS of the prostate of a young volunteer. 
82 
Based on these studies treatment schedules of HESW as monotherapy can be 
improved. Hoshi et al already suggested in 1991 that a decrease in time interval 
between HESW exposures might be beneficial67 Our studies described in chapter 6 
rationalizes a decrease to 2-3 hours 
Based on the study described in chapter 5 we recently hypothesized that the 
concentration of systemically given drugs can be locally increased by the application 
ot HESW 2S Until now several attempts have been made to increase TBF in order to 
overcome poor drug delivery due to heterogeneous blood supply 71 We however, 
demonstrated that a HESW induced decrease in tumor blood flow results in an 
increased local concentration of the systemically given drug 28 Thus lower doses of 
systemically given drugs, e g chemotherapeutics, with less general toxicity, may be 
necessary to achieve similar antitumor efficacy In a recent pilot study, combining low 
dose systemically given TNF-a with HESW, we achieved a higher percentage of 
complete responses in the combination group as compared to both treatments alone 
(unpublished results) 
Till now, MRS has only been used in urological oncology in an experimental setting 
to monitor alterations in metabolism alter therapy Currently, there have been only a 
limited number of, non-urological, in vivo MRS studies published using MRS for 
therapy evaluation Whether this technique will be applicable for therapy evaluation in 
urological oncology is not known yet The endorectal MRS prostate probe, currently 
experimentally used lor diagnosis, might also be benificial tor (hormonal) therapy 
evaluation Future will learn whether MRS will become an established tool in 
diagnosis and therapy monitoring in urological oncology 
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Stellingen behorend bij het proefsehrift 
M \ ( ; N F T K U R S O N A N C R SPECTROSCOPY IN l R O I . O G I C A L ONCOLOGN 
\an 
E.B. Cornel 
1. Magnetische kernspin resonantie spectroscopie (MUS) kan behulpzaam /ijn 
bij de diagnostiek λ an het adenncarcinoom \an de prostaat. 
Dn proef м.Ііп/1 
2. Met behulp \an MRS kan een onderscheid gemaakt «orden tussen prostaat-
carcinomen met \crschillend biologisch gedrag. 
Du proefohrift 
Τι. De anti-proliferatic\i' werking \an hoog-energetische schokgohen (HRSG) 
berust voornamelijk op een tijdelijke vermindering лап de doorbloeding лап 
de tumor. 
Пи proefsi liri/r 
4. De met HRSG samenhangende daling лап de tumor ллсеІЧеІ pil wordt 
\ nomamelijk легоог/aakt door een леі-hoogde mclk/uui s\ nthesc. 
Du priH'f\í hrifr. 
5. De intra-tumorale concentratie лап sistemiseli gegegeven TNK-u kan 
drievoudig лerhoogd ллorden door een lokale behandeling niet HESC. 
( iiriwl et til. Mihimtreil 
6. Het anti-tumor effect лап BC G berust op een lokale ллегкіп» en niet op een 
specifieke immunologische. 
( m nel cl ui I Imi. N9. Г -ІК2. IVVÌ 
Uiiili/f el ni I Imi. И«. ІОІН-І02І. l')')¡ 
7. Het ontbreken лап een cffectie\c fraudebestrijding aan de Nederlandse 
uni\ ersitciten devalueert de лл aarde лап de doctorandus graad. 
S. I)c kosten ten Ьсііослс лап de лolksgc7ondheid in Nederland /uilen blij\cn 
stijgen ллеіке maatregelen de oлerhcid ook neemt. (BaumoTs disease) 
Dientengevolge /uilen wijzigingen in het financicringssWceiii de/e groei 
alleen marginaal kunnen Ьеіпл locden. 
'). Weienschap is meten ллаі meetbaar is, en ллаі niel meetbaar is meetbaar 
maken. 
(•nllilei 
II). Zelfs de beste stelling houdt niet altijd stand. 



